Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Contraception and Contraceptive Drugs

  Free Subscription

Articles published in Contraception

Retrieve available abstracts of 430 articles:
HTML format

Single Articles

    June 2024
  1. UPADHYAY UD, Adkins CE
    Deception by obfuscation: Studnicki et al.'s retracted longitudinal cohort study of emergency room utilization following abortion.
    Contraception. 2024;134:110417.
    PubMed     Abstract available

  2. DUTTON C, Mody SK, Nippita S, Dodge LE, et al
    Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications.
    Contraception. 2024;134:110418.
    PubMed     Abstract available

    May 2024
  3. MAHR NM, Brown JE
    Contraception and Abortion Attitudes Among Military Medical Students: An Exploratory Study.
    Contraception. 2024 May 15:110489. doi: 10.1016/j.contraception.2024.110489.
    PubMed     Abstract available

  4. KENDALL PD, Bresnitz W, Huang J, Sheeder J, et al
    A retrospective analysis of factors associated with deep contraceptive implant removals compared to superficial removals.
    Contraception. 2024 May 14:110486. doi: 10.1016/j.contraception.2024.110486.
    PubMed     Abstract available

  5. HEGGIE C, Tong L, Heran A, Bhambhani I, et al
    The role of doulas and community birth workers in abortion and contraception care: An international scoping review.
    Contraception. 2024 May 9:110482. doi: 10.1016/j.contraception.2024.110482.
    PubMed     Abstract available

  6. STEVENSON TB, Thapaliya K, Moore V, Mazza D, et al
    Accessibility of oral emergency contraceptives in Australian community pharmacies.
    Contraception. 2024 May 4:110480. doi: 10.1016/j.contraception.2024.110480.
    PubMed     Abstract available

  7. SIMS JC, Harris JN, Katzman CL, Wong C, et al
    Confidence in adolescent contraceptive counseling among residents and fellows training at the University of Texas Southwestern in Dallas, Texas.
    Contraception. 2024 May 3:110478. doi: 10.1016/j.contraception.2024.110478.
    PubMed     Abstract available

  8. LAURORA I, Henrie B, Guillard H, Bradford R, et al
    Evaluation of adherence to a daily progestin-only pill in a simulated over-the-counter setting.
    Contraception. 2024;133:110388.
    PubMed     Abstract available

  9. LA SAPONARA V, Wan S, Nagarkar B, Zwain F, et al
    Understanding the mechanical behavior of intrauterine devices during simulated removal.
    Contraception. 2024;133:110399.
    PubMed     Abstract available

  10. DAVIS S, Parthun K, Friend DR
    A nine-month repeat-dose intravaginal ring (Ovaprene) irritation study in sheep.
    Contraception. 2024;133:110387.
    PubMed     Abstract available

  11. PERELLO-CAPO J, Estadella-Tarriel J, Gich-Saladich I, Bailon-Queiruga M, et al
    Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm(2) intrauterine device: Results of a phase 4 randomized controlled trial.
    Contraception. 2024;133:110367.
    PubMed     Abstract available

    April 2024
  12. JENSEN JT, Edelman A, Westhoff CL, Schreiber CA, et al
    Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trial.
    Contraception. 2024 Apr 24:110475. doi: 10.1016/j.contraception.2024.110475.
    PubMed     Abstract available

  13. EDELMAN A, Jensen JT, Brown J, Thomas M, et al
    Emergency contraception for individuals weighing 80kg or greater: a randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.
    Contraception. 2024 Apr 23:110474. doi: 10.1016/j.contraception.2024.110474.
    PubMed     Abstract available

  14. MITCHELL JA, Yao M, Maeda R, Lappen JR, et al
    Permanent and Long-Acting Reversible Contraception volumes at a multi-hospital system in Ohio before and after Dobbs.
    Contraception. 2024 Apr 20:110471. doi: 10.1016/j.contraception.2024.110471.
    PubMed     Abstract available

  15. BRANDER C, Risher K, Odwe G, Wado YD, et al
    Individual, partner, and community variables associated with method-specific contraceptive beliefs in urban and rural Kenya.
    Contraception. 2024 Apr 17:110470. doi: 10.1016/j.contraception.2024.110470.
    PubMed     Abstract available

  16. CONGDON JL, Vittinghoff E, Dehlendorf C
    Comparison of a Person-Centered Pregnancy Prevention Question and One Key Question(R) to Assess Postpartum Contraceptive Needs.
    Contraception. 2024 Apr 16:110465. doi: 10.1016/j.contraception.2024.110465.
    PubMed     Abstract available

  17. MASTERS GA, Julce C, Carroll S, Person SD, et al
    Association of Perinatal Depression and Postpartum Contraception Intent, Choice, and Actual Use.
    Contraception. 2024 Apr 5:110447. doi: 10.1016/j.contraception.2024.110447.
    PubMed     Abstract available

  18. LAZARIS E, Sanders JN, Carter G, Olsen J, et al
    Contraceptive uptake among gender-expansive individuals in the HER Salt Lake Contraceptive Initiative.
    Contraception. 2024 Apr 5:110446. doi: 10.1016/j.contraception.2024.110446.
    PubMed     Abstract available

  19. HAEDER SF, Marthey D, Skinner D
    US public opinion about reproductive health care in school-based health centers.
    Contraception. 2024;132:110374.
    PubMed     Abstract available

  20. LAMBERT SJ, Lunde B, Porsch L, Stoffels G, et al
    Adjuvant misoprostol or mifepristone for cervical preparation with osmotic dilators before dilation and evacuation.
    Contraception. 2024;132:110364.
    PubMed     Abstract available

  21. FREE LL, Brown BP, Matteson KA, Cronin B, et al
    Longitudinal impact of a residency-based postplacental levonorgestrel intrauterine device insertion program: Expulsion rates in years 1, 2, and 3.
    Contraception. 2024;132:110362.
    PubMed     Abstract available

  22. SIUM AF, Teklu H, Reeves M, Tolu LB, et al
    One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study.
    Contraception. 2024;132:110356.
    PubMed     Abstract available

    March 2024
  23. LANDS M, Dyer RL, Seymour JW
    Corrigendum to: "Sampling strategies among studies of barriers to abortion in the United States: A scoping review of abortion access research'' [Contraception 2024; 131:110342].
    Contraception. 2024 Mar 29:110435. doi: 10.1016/j.contraception.2024.110435.

    The Demand for Male Contraception: estimating the potential market for users of novel male contraceptive methods using United States National Survey of Family Growth data.
    Contraception. 2024 Mar 28:110438. doi: 10.1016/j.contraception.2024.110438.
    PubMed     Abstract available

  25. MONACO AE, Westhoff CL
    Evaluating virtual visits for contraceptive counseling: an exploratory study using the Person-Centered Contraceptive Counseling (PCCC) scale, a patient-reported outcome measure.
    Contraception. 2024 Mar 27:110443. doi: 10.1016/j.contraception.2024.110443.
    PubMed     Abstract available

  26. CLURE C, Sheeder J, Lazorwitz A
    Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant.
    Contraception. 2024 Mar 27:110442. doi: 10.1016/j.contraception.2024.110442.
    PubMed     Abstract available

  27. STEWART A, Lisa Romero, Kortsmit K, Hurst S, et al
    Long-Acting Reversible Contraception Use and Unmet Desire among Patients After the Zika Contraception Access Network Program in Puerto Rico.
    Contraception. 2024 Mar 27:110441. doi: 10.1016/j.contraception.2024.110441.
    PubMed     Abstract available

  28. MAUCK C, Thurman A, Jensen JT, Schreiber CA, et al
    Safety Testing of Ovaprene: an Investigational Non-Hormonal Monthly Vaginal Contraceptive.
    Contraception. 2024 Mar 27:110440. doi: 10.1016/j.contraception.2024.110440.
    PubMed     Abstract available

  29. HUMPHREYS A, Stevenson AJ, Yeatman S
    Changes in Contraceptive Method Mix Following the Colorado Family Planning Initiative.
    Contraception. 2024 Mar 21:110422. doi: 10.1016/j.contraception.2024.110422.
    PubMed     Abstract available

  30. YARGER J, Hopkins K, Elmes S, Rossetto I, et al
    Use of telemedicine to obtain contraception among young adults: Inequities by health insurance.
    Contraception. 2024 Mar 9:110419. doi: 10.1016/j.contraception.2024.110419.
    PubMed     Abstract available

  31. WAGNER B, Cleland K
    Increases in Retail Sales of Over-the-counter Levonorgestrel Emergency Contraception in the United States, 2016-2022.
    Contraception. 2024 Mar 8:110420. doi: 10.1016/j.contraception.2024.110420.
    PubMed     Abstract available

  32. COMFORT AB, Alvarez A, Goodman S, Upadhyay U, et al
    Provision of DMPA-SC for self-administration in different practice settings during the COVID-19 pandemic: Data from providers across the United States.
    Contraception. 2024;131:110360.
    PubMed     Abstract available

  33. SANDOVAL S, Rafie S, Kully G, Mody S, et al
    Pharmacist provision of medication abortion: A pilot study.
    Contraception. 2024;131:110346.
    PubMed     Abstract available

  34. JOHNSON DM, Ramaswamy S, Gomperts R
    Experiences with misoprostol-only used for self-managed abortion and acquired from an online or retail pharmacy in the United States.
    Contraception. 2024;131:110345.
    PubMed     Abstract available

  35. BHARADWA S, Fulcher I, Fortin J, Pocius KD, et al
    hCG trends after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Contraception. 2024;131:110343.
    PubMed     Abstract available

  36. RAYMOND EG, Frye LJ, Tocce K, Gingras S, et al
    Evaluation of a "smart" screening tool for asynchronous assessment of medication abortion eligibility: A pilot study.
    Contraception. 2024;131:110340.
    PubMed     Abstract available

    February 2024
  37. MEURICE ME, Mody SK, Nodora J, Marengo A, et al
    Social determinants of choosing telemedicine for contraceptive care: a retrospective cohort study.
    Contraception. 2024 Feb 29:110414. doi: 10.1016/j.contraception.2024.110414.
    PubMed     Abstract available

  38. TSEVAT D, Mercier R, Bernheimer C, Lin S, et al
    Amenorrhea in Adolescents Using the Etonogestrel Contraceptive Implant.
    Contraception. 2024 Feb 22:110413. doi: 10.1016/j.contraception.2024.110413.
    PubMed     Abstract available

  39. SOBER S, Bradford R, Henrie B, Pradeau S, et al
    Evaluation of consumer self-selection of a proposed over-the-counter, progestin-only daily oral contraceptive.
    Contraception. 2024 Feb 21:110401. doi: 10.1016/j.contraception.2024.110401.
    PubMed     Abstract available

  40. SAKTHIVEL M, Wolff H, Monast K, McHugh A, et al
    Mifepristone implementation in primary care: Clinician and staff insights from a pilot learning collaborative.
    Contraception. 2024;130:110280.
    PubMed     Abstract available

    January 2024
  41. PAIK J, Haenisch M, Kim A, Snyder JM, et al
    Corrigendum to: "Return to fertility, toxicology, and transgenerational impact of treatment with WIN 18,446, a potential male contraceptive, in mice" [Contraception. 129 (2024) 110306].
    Contraception. 2024 Jan 22:110371. doi: 10.1016/j.contraception.2024.110371.

  42. BOEHNKE T, Franke C, Bauerfeind A, Heinemann K, et al
    Systematic analysis of combined oral contraceptive prescription patterns in psychotropic drug users across 12 European countries.
    Contraception. 2024 Jan 20:110375. doi: 10.1016/j.contraception.2024.110375.
    PubMed     Abstract available

  43. FATIMA LL, Alonso Llamazares MJ, Mausbach Reisen H, Parra Ribes I, et al
    Impact of the hands-on Clinical Training Program (CTP) for subdermic implant on contraceptive counselling and users' choice in Spain: A six months follow up study.
    Contraception. 2024 Jan 16:110372. doi: 10.1016/j.contraception.2024.110372.
    PubMed     Abstract available

  44. MAUCK C, Thurman A, Jensen JT, Schreiber CA, et al
    Successful Postcoital Testing of Ovaprene: an Investigational Non-Hormonal Monthly Vaginal Contraceptive.
    Contraception. 2024 Jan 15:110373. doi: 10.1016/j.contraception.2024.110373.
    PubMed     Abstract available

  45. GAWRON LM, Kaiser JE, Gero A, Sanders JN, et al
    Pharmacodynamic evaluation of the etonogestrel contraceptive implant initiated midcycle with and without ulipristal acetate: an exploratory study.
    Contraception. 2024 Jan 15:110370. doi: 10.1016/j.contraception.2024.110370.
    PubMed     Abstract available

  46. CARRANCO S, Bohac S, Casey S, Sangi-Haghpeykar H, et al
    A Survey Of Contraceptive Method Use Among Patients With Delayed Permanent Contraception Due To The COVID-19 Pandemic.
    Contraception. 2024 Jan 13:110369. doi: 10.1016/j.contraception.2024.110369.
    PubMed     Abstract available

  47. HALE N, Dehlendorf C, Smith MG, Stapleton J, et al
    Contraceptive Counseling, Method Satisfaction, and Planned Method Continuation among Women in the U.S. Southeast.
    Contraception. 2024 Jan 10:110365. doi: 10.1016/j.contraception.2024.110365.
    PubMed     Abstract available

  48. LAPORTE M, Marcelino AC, Pereira PDC, Espejo-Arce X, et al
    Uptake, discontinuation, and continuation rate of long-acting contraceptive methods (LARC) when offered at no cost in Campinas, Brazil.
    Contraception. 2024 Jan 7:110363. doi: 10.1016/j.contraception.2024.110363.
    PubMed     Abstract available

  49. SOKOL NA, Sawadogo N, Bullington BW, Tumlinson K, et al
    Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.
    Contraception. 2024;129:110302.
    PubMed     Abstract available

  50. GEDESTAD I, Munnangi M, Chamberlain A, Shabaik S, et al
    Five years later: Can women in Los Angeles County, California, get adequate pill supplies?
    Contraception. 2024;129:110294.
    PubMed     Abstract available

    December 2023
  51. YI H, Stamm CA, Wright G, Mondie WS, et al
    Emergency contraception in a historic southern city: mystery caller study in Birmingham, Alabama.
    Contraception. 2023 Dec 29:110361. doi: 10.1016/j.contraception.2023.110361.
    PubMed     Abstract available

  52. BORGES ALV, Lay AAR, Duarte LS, Chofakian CBDN, et al
    Changes in contraceptive use during the second COVID-19 lockdown in Brazil: a web-based survey.
    Contraception. 2023 Dec 28:110359. doi: 10.1016/j.contraception.2023.110359.
    PubMed     Abstract available

  53. SINTHUCHAI N, Tapanwong N, Apirakviriya C, Pohthipornthawat N, et al
    The effect of a single-dose of a combination injectable contraceptive for treatment of bothersome uterine bleeding in contraceptive implant(s) users; a randomized double-blind placebo-controlled trial.
    Contraception. 2023 Dec 14:110354. doi: 10.1016/j.contraception.2023.110354.
    PubMed     Abstract available

  54. DOTY N, Beckley E, Garg B, Maristany S, et al
    Changes in hair cortisol concentration in intrauterine device initiators: A prospective cohort study.
    Contraception. 2023;128:110142.
    PubMed     Abstract available

  55. CHATILLON A, Vizcarra E, Kumar B, Dickman SL, et al
    Access to care following Planned Parenthood's termination from Texas' Medicaid network: A qualitative study.
    Contraception. 2023;128:110141.
    PubMed     Abstract available

  56. SPIELVOGEL R, Stephens RB, Clark R, Guillen M, et al
    Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial.
    Contraception. 2023;128:110133.
    PubMed     Abstract available

    November 2023
  57. STOWERS P, Heck R, Csiszar K, Kaneshiro B, et al
    Corrigendum to "Just world beliefs and community-level abortion stigma: An exploratory survey" [Contraception 2023;122:109979].
    Contraception. 2023 Nov 27:110341. doi: 10.1016/j.contraception.2023.110341.

  58. GAWRON LM, Sexsmith CD, Carter G, Kaiser JE, et al
    Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study.
    Contraception. 2023 Nov 24:110344. doi: 10.1016/j.contraception.2023.110344.
    PubMed     Abstract available

  59. SZNAJDER K, Thaler K, Perin J, Burke AE, et al
    Development and evaluation of measures to assess self-determination in peripartum contraceptive decision-making.
    Contraception. 2023 Nov 16:110329. doi: 10.1016/j.contraception.2023.110329.
    PubMed     Abstract available

  60. PERELLO-CAPO J, Estadella-Tarriel J, Gich-Saladich I, Bailon-Queiruga M, et al
    Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm(2) intrauterine device: Results of a 3-year, single-center, randomized phase 4 study.
    Contraception. 2023;127:110127.
    PubMed     Abstract available

  61. RAYMOND EG, Weaver MA, Shochet T
    Effectiveness and safety of misoprostol-only for first-trimester medication abortion: An updated systematic review and meta-analysis.
    Contraception. 2023;127:110132.
    PubMed     Abstract available

    October 2023
  62. JONAS K, Bergh K, Duby Z, Mangoale K, et al
    Using prevention cascades to investigate coverage of contraception services among young women enrolled in a large-scale combination HIV prevention programme in South Africa.
    Contraception. 2023 Oct 18:110307. doi: 10.1016/j.contraception.2023.110307.
    PubMed     Abstract available

  63. STANCZYK FZ, Winer SA, Foidart JM, Archer DF, et al
    Comparison of Estrogenic Components Used for Hormonal Contraception.
    Contraception. 2023 Oct 18:110310. doi: 10.1016/j.contraception.2023.110310.
    PubMed     Abstract available

  64. LINDER M, Schoendorf J, Pisa F, Schulze-Rath R, et al
    Characteristics and hormonal contraception use patterns of levonorgestrel 13.5 mg intrauterine device users in Sweden 2014-2016.
    Contraception. 2023 Oct 14:110309. doi: 10.1016/j.contraception.2023.110309.
    PubMed     Abstract available

  65. PAIK J, Haenisch M, Kim A, Snyder JM, et al
    Return to Fertility, Toxicology, and Transgenerational Impact of Treatment with WIN 18,446, a Potential Male Contraceptive, in Mice.
    Contraception. 2023 Oct 7:110306. doi: 10.1016/j.contraception.2023.110306.
    PubMed     Abstract available

  66. WINGO E, Dehlendorf C
    Lack of pregnancy intention or interest in pregnancy prevention now? How best to screen for desire for contraceptive care.
    Contraception. 2023 Oct 6:110303. doi: 10.1016/j.contraception.2023.110303.
    PubMed     Abstract available

  67. WOLFF H, McHugh A, Qadir S, Lassar M, et al
    Reproductive care in community health centers: Multi-method evaluation of the Illinois Contraceptive Access Now (ICAN!) demonstration program.
    Contraception. 2023 Oct 6:110305. doi: 10.1016/j.contraception.2023.110305.
    PubMed     Abstract available

  68. SHIM JY, Ryan ME, Milliren CE, Maslyanskaya S, et al
    Continuation Rates of Hormonal Intrauterine Devices in Adolescents and Young Adults when placed for Contraceptive and Non-Contraceptive Indications.
    Contraception. 2023 Oct 6:110304. doi: 10.1016/j.contraception.2023.110304.
    PubMed     Abstract available

  69. COSTANZO MA, Magnuson KA, Gennetian LA, Halpern-Meekin S, et al
    Contraception Use and Satisfaction Among Mothers with Low-Income: Evidence from the Baby's First Years Study.
    Contraception. 2023 Oct 6:110297. doi: 10.1016/j.contraception.2023.110297.
    PubMed     Abstract available

  70. JANTTI C, Toffol E, Partonen T, Haukka J, et al
    Contraceptive plans and purchase after an induced abortion: a nationwide register study from Finland.
    Contraception. 2023 Oct 5:110299. doi: 10.1016/j.contraception.2023.110299.
    PubMed     Abstract available

  71. DIAMOND B, Sheeder J, Lazorwitz A
    An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.
    Contraception. 2023 Oct 4:110298. doi: 10.1016/j.contraception.2023.110298.
    PubMed     Abstract available

  72. STODDARD RE, Pelletier A, Sundquist EN, Haas-Kogan ME, et al
    Popular Contraception Videos on TikTok: An Assessment of Content Topics.
    Contraception. 2023 Oct 4:110300. doi: 10.1016/j.contraception.2023.110300.
    PubMed     Abstract available

  73. BAKER CC, Wu BT, Han G, Flynn AN, et al
    Early pregnancy loss medical management in clinical practice.
    Contraception. 2023;126:110134.
    PubMed     Abstract available

  74. JUAREZ-CHAVEZ E, Villalobos Ruiz JH, Carrasco Navarro RM, Guerrero Vasquez R, et al
    Exploring the prevalence of abortion and its characteristics in Peru.
    Contraception. 2023;126:110115.
    PubMed     Abstract available

  75. NEILL S, Hoe E, Fortin J, Goldberg AB, et al
    Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use.
    Contraception. 2023;126:110108.
    PubMed     Abstract available

  76. RAYMOND EG, Weaver MA, Shochet T, Grant M, et al
    Clinical outcomes of medication abortion using misoprostol-only: A retrospective chart review at an abortion provider organization in the United States.
    Contraception. 2023;126:110109.
    PubMed     Abstract available

    September 2023
  77. JONAS K, Lombard C, Chirinda W, Govindasamy D, et al
    Corrigendum to "Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross-sectional analysis in six South African districts" [Contraception 116 (2022) 51-58].
    Contraception. 2023 Sep 22:110281. doi: 10.1016/j.contraception.2023.110281.

  78. ROBERTS CM, Smalley JM, Adelman WP, Weir LF, et al
    Brief Report: Influence of mandatory contraceptive education emphasizing long-acting reversible methods on continuation rates among military recruits.
    Contraception. 2023 Sep 20:110295. doi: 10.1016/j.contraception.2023.110295.
    PubMed     Abstract available

  79. GAGE AJ, Akilimali PZ, Wood FE, Gay R, et al
    Evaluation of the effect of the Momentum project on family planning outcomes among first-time mothers aged 15-24 years in Kinshasa, DRC.
    Contraception. 2023;125:110088.
    PubMed     Abstract available

  80. DE LOTT LB, Moniz MH, Niziol LM, Khanna S, et al
    Levonorgestrel intrauterine device use and incident idiopathic intracranial hypertension among commercially insured women.
    Contraception. 2023;125:110089.
    PubMed     Abstract available

  81. SIUM AF, Shimeles T, Gudu W
    The effect of induced fetal demise on induction to expulsion interval during later medication abortion: A retrospective cohort.
    Contraception. 2023;125:110092.
    PubMed     Abstract available

  82. DICKINSON JE, Doherty DA
    Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol.
    Contraception. 2023;125:110080.
    PubMed     Abstract available

    August 2023
  83. JONES A, Whitesell C, Tadikonda A, Perry MF, et al
    "I feel like it gives me what I need to know": A qualitative study on adolescent perceptions of two contraceptive decision aids.
    Contraception. 2023 Aug 31:110277. doi: 10.1016/j.contraception.2023.110277.
    PubMed     Abstract available

  84. XUAN NGUYEN TT, Quynh Nguyen TT, Huong Le L, Dinh DX, et al
    Knowledge, attitudes, and practices towards emergency contraceptive pills among community pharmacists and pharmacy customers: a cross-sectional study in urban Vietnam.
    Contraception. 2023 Aug 30:110275. doi: 10.1016/j.contraception.2023.110275.
    PubMed     Abstract available

  85. THOMAS K, Malhotra T, Ngendahimana D, Gibson KS, et al
    Postpartum contraceptive choice and fulfillment in patients with opioid use disorder.
    Contraception. 2023 Aug 24:110267. doi: 10.1016/j.contraception.2023.110267.
    PubMed     Abstract available

  86. MAUCK CK, Dart C, Thurman A, Creinin MD, et al
    Contraceptive efficacy should primarily be measured using life table pregnancy rates.
    Contraception. 2023 Aug 8:110140. doi: 10.1016/j.contraception.2023.110140.

  87. QASBA NT, Wallace KF, Yu V, Capoccia KL, et al
    Online survey of consumer awareness and perceptions of a Massachusetts law for 12-month-supply of contraception.
    Contraception. 2023 Aug 4:110138. doi: 10.1016/j.contraception.2023.110138.
    PubMed     Abstract available

  88. CREININ MD, Angulo A, Colli E, Archer DF, et al
    The efficacy, safety and tolerability of an estrogen-free oral contraceptive drospirenone 4 mg (24/4-day regimen) in obese users.
    Contraception. 2023 Aug 4:110136. doi: 10.1016/j.contraception.2023.110136.
    PubMed     Abstract available

  89. ANGER HA, Raymond EG
    Implications of using home urine pregnancy tests versus facility-based tests for assessment of outcome following medication abortion provided via telemedicine.
    Contraception. 2023;124:110055.
    PubMed     Abstract available

    July 2023
  90. ABERNATHEY L, Ryan ME, Golub S, Ahrens K, et al
    Long-acting Reversible Contraception in Gender-Diverse Adolescents and Young Adults: Outcomes from a Multisite Collaborative.
    Contraception. 2023 Jul 28:110131. doi: 10.1016/j.contraception.2023.110131.
    PubMed     Abstract available

  91. JENSEN JT, Waites BT, Boniface ER, McCrimmon S, et al
    Development and validation of an expanded panel of progestins using liquid chromatography-tandem triple quadrupole mass spectrometry (LC-MS/MS) to monitor protocol compliance in hormonal contraceptive pharmacokinetic/pharmacodynamic studies.
    Contraception. 2023 Jul 25:110130. doi: 10.1016/j.contraception.2023.110130.
    PubMed     Abstract available

  92. FREEMAN E, Paul R, Dorsey M, Madden T, et al
    Comparison of interpersonal quality of contraceptive counseling delivered via telehealth versus in-person.
    Contraception. 2023 Jul 25:110129. doi: 10.1016/j.contraception.2023.110129.
    PubMed     Abstract available

  93. RUELLE Y, Haghighi S, Guillot O
    Effects of a short training workshop on the insertion/removal of intrauterine devices and contraceptive implants by general practice residents and their supervisors.
    Contraception. 2023 Jul 17:110117. doi: 10.1016/j.contraception.2023.110117.
    PubMed     Abstract available

  94. GUTMAN S, Connor H, Mumford SL, Gilmore E, et al
    Feasibility and acceptability of virtual group contraceptive counseling prior to abortion care.
    Contraception. 2023 Jul 17:110114. doi: 10.1016/j.contraception.2023.110114.
    PubMed     Abstract available

  95. ROSENBERG JD, Raymond E, Shochet T
    Corrigendum to "An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States" Contraception, Volume 122, 109996 (June 2023).
    Contraception. 2023 Jul 5:110098. doi: 10.1016/j.contraception.2023.110098.

  96. RODRIGUEZ MI, Acevedo AM, Renfro S, Tasset J, et al
    Association of intrapartum severe maternal morbidity with receipt of postpartum contraception among Medicaid recipients.
    Contraception. 2023 Jul 4:110110. doi: 10.1016/j.contraception.2023.110110.
    PubMed     Abstract available

  97. FIASTRO AE, Young E, Jacob-Files E, Ruben MR, et al
    Advance provision of medication for induced abortion: A qualitative study of patient perspectives.
    Contraception. 2023;123:110050.
    PubMed     Abstract available

  98. DICENZO N, Shah N, Glassman D, Singla A, et al
    Active COVID-19 infection as a barrier to postpartum tubal ligation.
    Contraception. 2023;123:110051.
    PubMed     Abstract available

  99. SMITH TJ, Urdanigo TK, Shroff N, Rubin SE, et al
    Patient's experience and satisfaction with self-administered subcutaneous depot medroxyprogesterone acetate use during the first year of COVID-19.
    Contraception. 2023;123:110008.
    PubMed     Abstract available

  100. BOEHNKE T, Eggebrecht L, Viet M, Heinemann K, et al
    How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?
    Contraception. 2023;123:110003.
    PubMed     Abstract available

  101. YARON M, Legardeur H, Barcellini B, Akhoundova F, et al
    Safety and efficacy of a suction cervical stabilizer for intrauterine contraceptive device insertion: Results from a randomized, controlled study.
    Contraception. 2023;123:110004.
    PubMed     Abstract available

    June 2023
  102. SILEO KM, Muhumuza C, Wanyenze RK, Kershaw TS, et al
    A pilot quasi-experimental controlled trial of a community-based, multi-level family planning intervention for couples in rural Uganda: evidence of feasibility, acceptability, and effect on contraceptive uptake among those with an unmet need for famil
    Contraception. 2023 Jun 22:110096. doi: 10.1016/j.contraception.2023.110096.
    PubMed     Abstract available

  103. BREWER M, Clifton T
    Religious affiliation and women's receipt of person-centered contraceptive care: Findings from the National Survey of Family Growth, 2017-2019.
    Contraception. 2023 Jun 19:110097. doi: 10.1016/j.contraception.2023.110097.
    PubMed     Abstract available

  104. LAZORWITZ A, Sheeder J
    Validation of 24-hour trough concentration as a proxy for intensive pharmacokinetic measurements for a combined oral contraceptive pill containing desogestrel.
    Contraception. 2023 Jun 16:110093. doi: 10.1016/j.contraception.2023.110093.
    PubMed     Abstract available

  105. KUS LH, Paul R, Nigaglioni Rivera A, Zeal C, et al
    Improvement in contraceptive knowledge after using an online educational resource.
    Contraception. 2023 Jun 16:110095. doi: 10.1016/j.contraception.2023.110095.
    PubMed     Abstract available

  106. OSTERBUR BADHEY ML, Li S, Alimena S, Johnson NR, et al
    Allergic and infectious complications of Etonogestrel implant placements: A case series.
    Contraception. 2023;122:109994.
    PubMed     Abstract available

  107. ANJOS FCQS, Marcelino AC, Espejo-Arce X, Pereira PDC, et al
    Pain and ease of insertion of three different intrauterine devices in Brazilian adolescents: A participant-blinded randomized trial.
    Contraception. 2023;122:109997.
    PubMed     Abstract available

  108. WOLLUM A, Zuniga C, Blanchard K, Teal S, et al
    A commentary on progestin-only pills and the "three-hour window" guidelines: Timing of ingestion and mechanisms of action.
    Contraception. 2023;122:109978.
    PubMed     Abstract available

  109. CIRRINCIONE LR, Nakalema S, Chappell CA, Byakika-Kibwika P, et al
    Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
    Contraception. 2023;122:109975.
    PubMed     Abstract available

    May 2023
  110. MANG A, Jetelina KK, Mcneely C, Durante JC, et al
    Characteristics of parents who think intrauterine devices or contraceptive implants are "best" for their daughter: An exploratory analysis.
    Contraception. 2023 May 30:110084. doi: 10.1016/j.contraception.2023.110084.
    PubMed     Abstract available

  111. LOH M, Niu L, Arden M, Burk RD, et al
    Long-acting reversible contraception and condom use: A cohort study of female adolescents and young adults in New York City.
    Contraception. 2023 May 30:110081. doi: 10.1016/j.contraception.2023.110081.
    PubMed     Abstract available

  112. SULGER E, Jung C, Nippita S
    Avoiding unintended pregnancy during transition from copper intrauterine device to etonogestrel contraceptive implant: A case report.
    Contraception. 2023 May 29:110085. doi: 10.1016/j.contraception.2023.110085.
    PubMed     Abstract available

  113. SONALKAR S, Kete C, McAllister A, Afreen R, et al
    Perceptions of HIV risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management in the United States.
    Contraception. 2023 May 18:110063. doi: 10.1016/j.contraception.2023.110063.
    PubMed     Abstract available

  114. AMORY JK, Blithe DL, Ware RS, Swerdloff RS, et al
    Design of an International Male Contraceptive Efficacy Trial Using a Self-Administered Daily Transdermal Gel Containing Testosterone and Segesterone Acetate (Nestorone(R)).
    Contraception. 2023 May 18:110064. doi: 10.1016/j.contraception.2023.110064.
    PubMed     Abstract available

  115. SHAW JG, Goldthwaite LM, Maric I, Shaw KA, et al
    Postpartum long-acting reversible contraception among privately insured: national analysis 2007-2016, by term and preterm birth.
    Contraception. 2023 May 18:110065. doi: 10.1016/j.contraception.2023.110065.
    PubMed     Abstract available

  116. FOSTER AM, Darney BG, Nguyen BT, Russo J, et al
    Advancing diversity, equity, inclusion, and anti-racism in Contraception: A statement of commitment from the Editorial Board.
    Contraception. 2023 May 17:110066. doi: 10.1016/j.contraception.2023.110066.

  117. ERMIAS Y, Averbach SH, Dey AK, Gebrehanna E, et al
    The Association Between Quality of Contraceptive Counseling and Selection of Contraceptive Method Post-counseling Among Women in Ethiopia.
    Contraception. 2023 May 11:110060. doi: 10.1016/j.contraception.2023.110060.
    PubMed     Abstract available

  118. RAYMOND EG, Mark A, Grossman D, Beasley A, et al
    Medication abortion with misoprostol-only: A sample protocol.
    Contraception. 2023;121:109998.

  119. KOENIG LR, Raymond EG, Gold M, Boraas CM, et al
    Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United States.
    Contraception. 2023;121:109962.
    PubMed     Abstract available

    April 2023
  120. RODRIGUEZ MI, Skye M, Schrote K, Linz R, et al
    Contraceptive services in Oregon's state-funded network during the COVID-19 pandemic.
    Contraception. 2023 Apr 21:110054. doi: 10.1016/j.contraception.2023.110054.
    PubMed     Abstract available

  121. JONES EJ, Dehlendorf C, Kriz R, Grzeniewski M, et al
    Using the Person-Centered Contraceptive Counseling (PCCC) Measure for Quality Improvement.
    Contraception. 2023 Apr 12:110040. doi: 10.1016/j.contraception.2023.110040.
    PubMed     Abstract available

  122. SHEA M, Decker E, LeRoy L, Winter M, et al
    Testing the Validity and Reliability of the Person-Centered Contraceptive Care (PCCC) Performance Measure in a Real-World Contraceptive Access Program.
    Contraception. 2023 Apr 6:110039. doi: 10.1016/j.contraception.2023.110039.
    PubMed     Abstract available

  123. PAI M, Rigler N, de Oliveira BR, Mody SK, et al
    "My implant is expiring": A national U.S. mystery shopper study regarding extended use of the contraceptive implant.
    Contraception. 2023 Apr 3:110038. doi: 10.1016/j.contraception.2023.110038.
    PubMed     Abstract available

  124. SHADY NW, Farouk HA, Sallam HF
    A randomized double blinded clinical trial to explore the clinical outcomes of vaginal isonicotinic acid hydrazide (INH) administration six hours prior to T380A intrauterine device insertion in persons delivered only by cesarean delivery. Contraceptio
    Contraception. 2023;120:109973.

  125. QUINN DA, Sileanu FE, Borrero S, Callegari LS, et al
    Reproductive health services: A missed opportunity in VA primary care?
    Contraception. 2023;120:109957.
    PubMed     Abstract available

  126. GILBERT AL, Gelfand D, Fortin J, Roncari D, et al
    At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
    Contraception. 2023;120:109955.
    PubMed     Abstract available

  127. JENSEN JT, Reinecke I, Post TM, Lukkari-Lax E, et al
    Extended use of levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg: A population pharmacokinetic approach to estimate in vivo levonorgestrel release rates and systemic exposure including comparison with two other LNG-IUSs.
    Contraception. 2023;120:109954.
    PubMed     Abstract available

  128. REED S, Minh TD, Lange JA, Koro C, et al
    Pregnancy and pregnancy outcomes in a prospective cohort study: Final results from the Nexplanon Observational Risk Assessment Study (NORA).
    Contraception. 2023;120:109920.
    PubMed     Abstract available

  129. SHOCHET T, Turok D, Frye LJ, Sexsmith CD, et al
    Single dose letrozole and misoprostol for termination of pregnancy through 63 days' gestation: A pilot study.
    Contraception. 2023;120:109924.
    PubMed     Abstract available

    March 2023
  130. LAZORWITZ A, Sheeder J, Teal S
    The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: a pharmacokinetic and pharmacodynamic study.
    Contraception. 2023 Mar 28:110035. doi: 10.1016/j.contraception.2023.110035.
    PubMed     Abstract available

  131. DEHLENDORF C, Vittinghoff E, Silverstein I, Fox E, et al
    Prioritizing Patient Experience: Validation of the Person-Centered Contraceptive Counseling Measure as a Performance Measure.
    Contraception. 2023 Mar 17:110010. doi: 10.1016/j.contraception.2023.110010.
    PubMed     Abstract available

  132. STUART GS, Yates L, Crump J, Allison BA, et al
    Single-visit insertion of long-acting reversible contraception in a single health system.
    Contraception. 2023 Mar 15:110009. doi: 10.1016/j.contraception.2023.110009.
    PubMed     Abstract available

  133. NGUYEN BT, Jacobsohn TL
    Men's willingness to use novel male contraception is linked to gender-equitable attitudes: results from an exploratory online survey.
    Contraception. 2023 Mar 14:110001. doi: 10.1016/j.contraception.2023.110001.
    PubMed     Abstract available

  134. WILKINSON TA, Meredith AH, Katz AJ, Meagher CG, et al
    Assessment of Adolescent Decision-Making Capacity for Pharmacy Access to Hormonal Contraception.
    Contraception. 2023 Mar 11:110002. doi: 10.1016/j.contraception.2023.110002.
    PubMed     Abstract available

  135. MERZ AA, Kerns JL, Logan R, Gutierrez S, et al
    Contraceptive care in the United States during the COVID-19 pandemic: a social media survey study of contraceptive access, telehealth use and telehealth quality.
    Contraception. 2023 Mar 3:110000. doi: 10.1016/j.contraception.2023.110000.
    PubMed     Abstract available

  136. ZUNIGA C, Blanchard K, Harper CC, Wollum A, et al
    Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review.
    Contraception. 2023;119:109925.
    PubMed     Abstract available

  137. BAUM SE, Sierra G, Grossman D, Vizcarra E, et al
    Comparing preference for and use of medication abortion in Texas after policy changes in 2014 and 2018.
    Contraception. 2023;119:109912.
    PubMed     Abstract available

  138. BAYARD KE, Fabricant SP, White JD, Gordon B, et al
    Infectious outcomes following immediate postplacental intrauterine device placement in the setting of chorioamnionitis: An exploratory, retrospective study.
    Contraception. 2023;119:109913.
    PubMed     Abstract available

  139. ARENA A, Moro E, Degli Esposti E, Zanello M, et al
    How much will it hurt? Factors associated with pain experience in women undergoing medication abortion during the first trimester.
    Contraception. 2023;119:109916.
    PubMed     Abstract available

  140. HAMRICK JE, Ahmed AE, Witkop CT, Manetz KE, et al
    Unintended pregnancy among U.S. military active duty servicemembers: Estimates for 2018 and trends since 2005.
    Contraception. 2023;119:109894.
    PubMed     Abstract available

    February 2023
  141. BURY F, Iguyovwe V, Trivett M, Baraitser P, et al
    Patterns of use of emergency and oral contraceptives from an online service in the UK during the COVID-19 pandemic: a quantitative study of routinely collected data.
    Contraception. 2023 Feb 25:109992. doi: 10.1016/j.contraception.2023.109992.
    PubMed     Abstract available

  142. THORNTON M, Arora KS
    Reproductive Justice in Post-Roe America: Impact of Restricted Abortion Access on Patients Seeking Permanent Contraception.
    Contraception. 2023 Feb 24:109995. doi: 10.1016/j.contraception.2023.109995.
    PubMed     Abstract available

  143. EDMONDSON S, Conrado AB, Loria H, McLeigh J, et al
    Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care.
    Contraception. 2023 Feb 23:109993. doi: 10.1016/j.contraception.2023.109993.
    PubMed     Abstract available

  144. THOMPSON EL, Galvin AM, Ashvita Garg M, Diener A, et al
    A Socioecological Perspective to Contraceptive Access for Women Experiencing Homelessness in the United States.
    Contraception. 2023 Feb 23:109991. doi: 10.1016/j.contraception.2023.109991.
    PubMed     Abstract available

  145. CONGY J, Bouyer J, de La Rochebrochard E
    Low-income women and use of prescribed contraceptives in a context of full health insurance coverage in France, 2019.
    Contraception. 2023 Feb 7:109976. doi: 10.1016/j.contraception.2023.109976.
    PubMed     Abstract available

  146. BIGGS MA, Serrano S, Valladares ES, Grossman D, et al
    Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product.
    Contraception. 2023;118:109906.
    PubMed     Abstract available

  147. FAY KE, Traore F, Amico JR
    Intrauterine device self-removal practices during the COVID-19 pandemic among family planning clinics.
    Contraception. 2023;118:109889.
    PubMed     Abstract available

  148. MINNS A, Dehlendorf C, Peahl AF, Heisler M, et al
    Elevating the Patient Voice in Contraceptive Care Quality Improvement: A Qualitative Study of Patient Preferences for Peripastum Contraceptive Care.
    Contraception. 2023 Feb 1:109960. doi: 10.1016/j.contraception.2023.109960.
    PubMed     Abstract available

    January 2023
  149. AGARWAL K, Dewan R
    Evaluation of acceptability, safety and continuation rates of centchroman as post-abortion nonsteroidal contraceptive pill.
    Contraception. 2023 Jan 31:109961. doi: 10.1016/j.contraception.2023.109961.
    PubMed     Abstract available

  150. RODRIGUEZ MI, Daly A, Meath T, Watson K, et al
    Catholic sole community hospital s are associated with decreased receipt of postpartum permanent contraception among Medicaid recipients.
    Contraception. 2023 Jan 25:109959. doi: 10.1016/j.contraception.2023.109959.
    PubMed     Abstract available

  151. SALCEDO J, Cleland K, Bartz D, Thompson I, et al
    Society of Family Planning Clinical Recommendations: Emergency contraception.
    Contraception. 2023 Jan 21:109958. doi: 10.1016/j.contraception.2023.109958.
    PubMed     Abstract available

  152. MOSLEY EA, Monaco A, Zite N, Rosenfeld E, et al
    U.S. physicians' perspectives on the complexities and challenges of permanent contraception provision.
    Contraception. 2023 Jan 11:109948. doi: 10.1016/j.contraception.2023.109948.
    PubMed     Abstract available

  153. KEY K, Wollum A, Asetoyer C, Cervantes M, et al
    Challenges accessing contraceptive care and interest in over-the-counter oral contraceptive pill use among Black, Indigenous, and people of color: an online cross-sectional survey.
    Contraception. 2023 Jan 11:109950. doi: 10.1016/j.contraception.2023.109950.
    PubMed     Abstract available

  154. SARAYANI A, Winterstein A, Cristofoletti R, Vozmediano V, et al
    Real-World Effect of a Potential Drug-Drug Interaction Between Topiramate and Oral Contraceptives on Unintended Pregnancy Outcomes.
    Contraception. 2023 Jan 11:109953. doi: 10.1016/j.contraception.2023.109953.
    PubMed     Abstract available

  155. SCARSI KK, Smeaton LM, Podany AT, Olefsky M, et al
    Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.
    Contraception. 2023 Jan 11:109951. doi: 10.1016/j.contraception.2023.109951.
    PubMed     Abstract available

  156. GUILLARD H, Laurora I, Sober S, Karapet A, et al
    Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.
    Contraception. 2023;117:7-12.
    PubMed     Abstract available

  157. GLASIER A, Edelman A, Creinin MD, Brache V, et al
    The effect of deliberate non-adherence to a norgestrel progestin-only pill: A randomized, crossover study.
    Contraception. 2023;117:1-6.
    PubMed     Abstract available

  158. LEE CM, Johns SL, Stulberg DB, Allen RH, et al
    Barriers to abortion provision in primary care in New England, 2019-2020: A qualitative study.
    Contraception. 2023;117:39-44.
    PubMed     Abstract available

    December 2022
  159. CARVAJAL D, Bevilacqua KG, Caldwell MT, Zambrana RE, et al
    Provider Perspectives on Patient-Centered Contraceptive Counseling for Latinas in Baltimore, MD.
    Contraception. 2022 Dec 16:109921. doi: 10.1016/j.contraception.2022.109921.
    PubMed     Abstract available

  160. BLACK KI, Trane W, Dorney E, Mola G, et al
    Corrigendum to "A cross-sectional study of factors associated with immediate postpartum uptake of contraceptive implants in Papua New Guinea" [Contraception 117C Pages 25-29].
    Contraception. 2022 Dec 15:109918. doi: 10.1016/j.contraception.2022.109918.

  161. QURESHY Z, Lokken RP, Kakar S, Grab J, et al
    Influence of Progestin-only Hormonal Use on Hepatocellular Adenomas: A Retrospective Cohort Study.
    Contraception. 2022 Dec 4:S0010-7824(22)00439.
    PubMed     Abstract available

  162. LAI R
    "Every Medicine Is Somewhat Poisonous": Understanding the Reluctance to Use Oral Contraceptives Among Unmarried Women Seeking Abortion in China.
    Contraception. 2022 Dec 3:S0010-7824(22)00437.
    PubMed     Abstract available

  163. HARADA T, Ota I, Kitawaki J, Momoeda M, et al
    Real-world outcomes of the levonorgestrel-releasing intrauterine system for heavy menstrual bleeding or dysmenorrhea in Japanese patients: A prospective observational study (J-MIRAI).
    Contraception. 2022;116:22-28.
    PubMed     Abstract available

  164. REYNOLDS-WRIGHT JJ, Woldetsadik MA, Morroni C, Cameron ST, et al
    Pain management for medical abortion before 14 weeks' gestation: A systematic review.
    Contraception. 2022;116:4-13.
    PubMed     Abstract available

    November 2022
  165. STEINER RJ, McDonald-Mosley R
    Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access.
    Contraception. 2022 Nov 28:109911. doi: 10.1016/j.contraception.2022.

  166. SATHAR Z, Singh S, Hussain S, Sadiq M, et al
    Contraception. 2022 Nov 26:S0010-7824(22)00433.
    PubMed     Abstract available

  167. HOLADAY LW, Gover M, Iyer SV, DeLuca JP, et al
    Effectiveness of training primary care internal medicine residents in etonogestrel implants and impact on their future practice: A cross-sectional study.
    Contraception. 2022;115:31-35.
    PubMed     Abstract available

  168. MANHART MD, Duane M
    A comparison of app-defined fertile days from two fertility tracking apps using identical cycle data.
    Contraception. 2022;115:12-16.
    PubMed     Abstract available

  169. KEMPPAINEN V, Mentula M, Palkama V, Heikinheimo O, et al
    Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized controlled trial.
    Contraception. 2022;115:6-11.
    PubMed     Abstract available

  170. YOUNG D, Fitzgerald K, Laursen L, Whitaker AK, et al
    Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.
    Contraception. 2022;115:62-66.
    PubMed     Abstract available

    October 2022
  171. AVERBACH S, Johns NE, Ghule M, Dixit A, et al
    Understanding quality of contraceptive counseling in the CHARM2 gender-equity focused family planning intervention: findings from a cluster randomized controlled trial among couples in rural India.
    Contraception. 2022 Oct 31. pii: S0010-7824(22)00421.
    PubMed     Abstract available

  172. CHEN MJ, Jensen JT, Kaunitz AM, Achilles SL, et al
    Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials.
    Contraception. 2022 Oct 15. pii: S0010-7824(22)00395.
    PubMed     Abstract available

  173. BLACK KI, Trane W, Dorney E, Mola G, et al
    A cross-sectional study of factors associated with immediate postpartum uptake of contraceptive implants in Papua New Guinea.
    Contraception. 2022 Oct 14. pii: S0010-7824(22)00390.
    PubMed     Abstract available

  174. GOYAL S, Monsour M, Ko JY, Curtis KM, et al
    Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.
    Contraception. 2022 Oct 12. pii: S0010-7824(22)00389.
    PubMed     Abstract available

  175. HOLT K, Karp C, Uttekar BV, Quintero X, et al
    Reduction of the Quality of Contraceptive Counseling (QCC) Scale to a Short Version (QCC-10) in Ethiopia, India, and Mexico.
    Contraception. 2022 Oct 12. pii: S0010-7824(22)00383.
    PubMed     Abstract available

  176. HENLEY C, Jenner E, Richardson B, Falk G, et al
    Non-Barrier Contraceptive Use Patterns Among Latina Adolescents Attending California Reproductive Health Centers: A Longitudinal Study.
    Contraception. 2022 Oct 11:9897. doi: 10.1016/j.contraception.2022.
    PubMed     Abstract available

  177. KAPLAN J, Turok DK, Gero A, Kaiser JE, et al
    Switching and discontinuation of participant-masked randomization to a copper or levonorgestrel intrauterine device when presenting for emergency contraception.
    Contraception. 2022 Oct 11. pii: S0010-7824(22)00386.
    PubMed     Abstract available

  178. WIMSETT DJ, Legget E, Roberts DH, Oyston DC, et al
    Factors associated with postpartum contraceptive planning in New Zealand.
    Contraception. 2022 Oct 11. pii: S0010-7824(22)00387.
    PubMed     Abstract available

  179. CROWE J, Cohen R
    Infected myometrial hematoma due to malpositioned levonorgestrel intrauterine device: A case report.
    Contraception. 2022;114:85-88.
    PubMed     Abstract available

  180. MILES C, Weidner A, Summit AK, Thomson CJ, et al
    Patient opinions on sexual and reproductive health services in primary care in rural and urban clinics.
    Contraception. 2022;114:26-31.
    PubMed     Abstract available

  181. ROTHSCHILD CW, Richardson BA, Guthrie BL, Drake AL, et al
    Trajectories of method dissatisfaction among Kenyan women using modern, reversible contraception: A prospective cohort study.
    Contraception. 2022 Oct 1. pii: S0010-7824(22)00380.
    PubMed     Abstract available

    September 2022
  182. LEE JK, Gutin SA, Getahun M, Okiring J, et al
    Condom, modern contraceptive, and dual method use are associated with HIV status and relationship concurrency in a context of high mobility: A cross-sectional study of women of reproductive age in rural Kenya and Uganda, 2016.
    Contraception. 2022 Sep 14. pii: S0010-7824(22)00248.
    PubMed     Abstract available

  183. KANGASNIEMI MH, Arffman RK, Haverinen A, Luiro K, et al
    Effects of estradiol- and ethinylestradiol-based contraceptives on adrenal steroids: A randomized trial.
    Contraception. 2022 Sep 6. pii: S0010-7824(22)00246.
    PubMed     Abstract available

  184. ENNIS M, Renner R, Guilbert E, Norman WV, et al
    Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey.
    Contraception. 2022;113:19-25.
    PubMed     Abstract available

  185. CLERMIDY H, Fabre D, Hugues JN, Alonso CG, et al
    Management of Etonogestrel implant migration into the pulmonary artery.
    Contraception. 2022;113:62-67.
    PubMed     Abstract available

    August 2022
  186. HANSEN K, Boniface ER, Darney BG
    Association of Title X clinic status with receipt of person-centered contraceptive counseling: a population-based study.
    Contraception. 2022 Aug 19. pii: S0010-7824(22)00222.
    PubMed     Abstract available

  187. SWAN LET, Vu H, Higgins JA, Bui LM, et al
    Exploring financial stress and resource deprivation as barriers to preferred contraceptive use in Wisconsin in 2021.
    Contraception. 2022 Aug 5. pii: S0010-7824(22)00220.
    PubMed     Abstract available

  188. CEULEMANS M, Willekens J, Cavens L, De Wulf I, et al
    Knowledge and counseling preferences of the public and pharmacy staff on emergency contraception: results of a cross-sectional study in Belgium.
    Contraception. 2022 Aug 3. pii: S0010-7824(22)00217.
    PubMed     Abstract available

  189. ROMERO D, Manze M, Roberts L, McGroarty A, et al
    Stakeholder perspectives in New York State on reproductive health and pregnancy intention screening in primary care: A qualitative study.
    Contraception. 2022;112:93-99.
    PubMed     Abstract available

  190. BRADFORD RD, Farnsworth SJ, Laurora I, Sober S, et al
    Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study.
    Contraception. 2022;112:48-53.
    PubMed     Abstract available

  191. WESTHOFF CL, Archer DF, Barnhart K, Darney P, et al
    Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens.
    Contraception. 2022;112:54-60.
    PubMed     Abstract available

  192. KOHN JE, Berlan ED, Tang JH, Beasley A, et al
    Society of Family Planning committee consensus on self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
    Contraception. 2022;112:11-13.
    PubMed     Abstract available

  193. HAN L, Creinin MD, Hemon A, Glasier A, et al
    Mechanism of action of a 0.075 mg norgestrel progestogen-only pill 2. Effect on cervical mucus and theoretical risk of conception.
    Contraception. 2022;112:43-47.
    PubMed     Abstract available

  194. GLASIER A, Edelman A, Creinin MD, Han L, et al
    Mechanism of action of norgestrel 0.075 mg a progestogen-only pill. I. Effect on ovarian activity.
    Contraception. 2022;112:37-42.
    PubMed     Abstract available

  195. MILES C, Ennamuri D, Yeh J, Shih G, et al
    Would you be interested in DMPA-SC? An implementation project in two urban primary care clinics.
    Contraception. 2022;112:116-119.
    PubMed     Abstract available

    July 2022
  196. KAUNITZ AM, Achilles SL, Zatik J, Weyers S, et al
    Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women.
    Contraception. 2022 Jul 31. pii: S0010-7824(22)00218.
    PubMed     Abstract available

  197. JENSEN JT, Kaunitz AM, Achilles SL, Zatik J, et al
    Pooled efficacy results of estetrol/drospirenone combined oral contraception phase 3 trials.
    Contraception. 2022 Jul 31. pii: S0010-7824(22)00215.
    PubMed     Abstract available

  198. JONAS K, Lombard C, Chirinda W, Govindasamy D, et al
    Participation in an HIV prevention intervention and access to and use of contraceptives among young women: a cross sectional analysis in six South African districts.
    Contraception. 2022 Jul 23. pii: S0010-7824(22)00199.
    PubMed     Abstract available

  199. HASSELBACHER L, Moore A, Thompson L, Tyler CP, et al
    Exploring Illinois Contraceptive Providers' Interest in Medication Abortion Training.
    Contraception. 2022 Jul 20. pii: S0010-7824(22)00198.
    PubMed     Abstract available

  200. NGUYEN BT, Jacobsohn TL
    Post-abortion contraception, an opportunity for male partners and male contraception.
    Contraception. 2022 Jul 20. pii: S0010-7824(22)00195.
    PubMed     Abstract available

    June 2022
  201. TUMLINSON K, Britton LE, Williams CR, Wambua DM, et al
    Contraceptive method denial as downward contraceptive coercion: a mixed-methods mystery client study in Western Kenya.
    Contraception. 2022 Jun 29. pii: S0010-7824(22)00170.
    PubMed     Abstract available

  202. CLELAND K, Kumar B, Kakkad N, Shabazz J, et al
    Now Is the Time to Safeguard Access to Emergency Contraception Before Abortion Restrictions Sweep the United States.
    Contraception. 2022 Jun 23. pii: S0010-7824(22)00167.
    PubMed     Abstract available

  203. DETHIER D, Qasba N, Kaneshiro B
    Society of Family Planning Clinical Recommendation: Extended Use of Long Acting Reversible Contraception.
    Contraception. 2022 Jun 15. pii: S0010-7824(22)00162.
    PubMed     Abstract available

  204. MANCHIKANTI GOMEZ A, Rafie S, Garner-Ford E, Arcara J, et al
    Community Perspectives on Pharmacist-Prescribed Hormonal Contraception in Rural California.
    Contraception. 2022 Jun 4. pii: S0010-7824(22)00153.
    PubMed     Abstract available

  205. FRIEDLANDER EB, Raidoo S, Soon R, Salcedo J, et al
    The experience of pain in real-time during medication abortion.
    Contraception. 2022;110:71-75.
    PubMed     Abstract available

  206. WHITEHOUSE KC, Shochet T, Lohr PA
    Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.
    Contraception. 2022;110:21-26.
    PubMed     Abstract available

  207. DUIJKERS IJM, Klipping C, Rautenberg T, Schug BS, et al
    Effect on ovarian activity and ovulation inhibition of different oral dosages of levonorgestrel.
    Contraception. 2022;110:6-15.
    PubMed     Abstract available

  208. CADDY C, Williams H, Hocking J, Coombe J, et al
    "I never went to see that doctor again": A qualitative study examining Australian women's experiences requesting removal of LARC within 12 months of insertion.
    Contraception. 2022;110:81-85.
    PubMed     Abstract available

    May 2022
  209. CREININ MD, Vieira CS, Westhoff CL, Mansour DJA, et al
    Recommendations for standardization of bleeding data analyses in contraceptive studies.
    Contraception. 2022 May 28. pii: S0010-7824(22)00152.
    PubMed     Abstract available

  210. WOODHAMS E, Samura T, White K, Patton E, et al
    Society of Family Planning Clinical Recommendations: Contraception and abortion care for persons who use substances.
    Contraception. 2022 May 26. pii: S0010-7824(22)00151.
    PubMed     Abstract available

  211. REED R, Osby O, Nelums M, Welchlin C, et al
    Contraceptive care experiences and preferences among Black women in Mississippi: A qualitative study.
    Contraception. 2022 May 26. pii: S0010-7824(22)00140.
    PubMed     Abstract available

  212. STIFANI BM, Madden T, Micks E, Moayedi G, et al
    Society of Family Planning Clinical Recommendations: Contraceptive Care in the Context of Pandemic Response.
    Contraception. 2022 May 17. pii: S0010-7824(22)00138.
    PubMed     Abstract available

  213. KOCH SK, Paul R, Addante AN, Brubaker A, et al
    Medicaid Reimbursement Program for Immediate Postpartum Long-Acting Reversible Contraception Improves Uptake Regardless of Insurance Status.
    Contraception. 2022 May 16. pii: S0010-7824(22)00137.
    PubMed     Abstract available

  214. AHMAD ZM, Noel NL, Rudd TM, Nadelson CS, et al
    Implementation of a Pharmacist-led Hormonal Contraceptive Prescribing Service in a Campus Community Pharmacy in Indiana, United States.
    Contraception. 2022 May 13. pii: S0010-7824(22)00133.
    PubMed     Abstract available

  215. SACK DE, Peetluk LS, Audet CM
    Couples-based interventions and postpartum contraceptive uptake: a systematic review.
    Contraception. 2022 May 13. pii: S0010-7824(22)00131.
    PubMed     Abstract available

  216. HELLWIG F, Ewerling F, Coll CVN, Barros AJD, et al
    The role of female permanent contraception in meeting the demand for family planning in low- and middle-income countries.
    Contraception. 2022 May 11. pii: S0010-7824(22)00135.
    PubMed     Abstract available

  217. JACOBSOHN T, Nguyen BT, Brown JE, Thirumalai A, et al
    Male Contraception is Coming: Who Do Men Want to Prescribe their Birth Control?
    Contraception. 2022 May 9. pii: S0010-7824(22)00132.
    PubMed     Abstract available

  218. MASTEN M, Larrea N, Schultz C, Lazorwitz A, et al
    Short-notice cancellations of laparoscopic permanent contraception.
    Contraception. 2022 May 8. pii: S0010-7824(22)00130.
    PubMed     Abstract available

  219. SOIN KS, Yeh PT, Gaffield ME, Ge C, et al
    Health workers' values and preferences regarding contraceptive methods globally: a systematic review.
    Contraception. 2022 May 5. pii: S0010-7824(22)00129.
    PubMed     Abstract available

  220. YEH PT, Kautsar H, Kennedy CE, Gaffield ME, et al
    Values and preferences for contraception: a global systematic review.
    Contraception. 2022 May 4. pii: S0010-7824(22)00128.
    PubMed     Abstract available

  221. ADASHI EY, Rajan RS, O'Mahony DP, Cohen IG, et al
    The next two decades of mifepristone at FDA: History as destiny().
    Contraception. 2022;109:1-7.
    PubMed     Abstract available

  222. RAZON N, Wulf S, Perez C, McNeil S, et al
    Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics,.
    Contraception. 2022;109:19-24.
    PubMed     Abstract available

  223. JARIENE K, Ulevicius J, Petrusaite A, Sirataviciene A, et al
    Sexual behavior of Lithuanian high school students.
    Contraception. 2022;109:62-67.
    PubMed     Abstract available

  224. BIGGS MA, Ralph L, Morris N, Ehrenreich K, et al
    A cross-sectional survey of U.S. abortion patients' interest in obtaining medication abortion over the counter.
    Contraception. 2022;109:25-31.
    PubMed     Abstract available

  225. FOSTER AM, Messier K, Aslam M, Shabir N, et al
    Community-based distribution of misoprostol for early abortion: Outcomes from a program in Sindh, Pakistan.
    Contraception. 2022;109:49-51.
    PubMed     Abstract available

  226. RUSSELL CB, Qasba N, Evans ML, Frankel A, et al
    Variation in the interpretation and application of the Medicaid sterilization consent form among Medicaid officials.
    Contraception. 2022;109:57-61.
    PubMed     Abstract available

  227. LAROCHE KJ, Wylie A, Persaud M, Foster AM, et al
    Integrating mifepristone into primary care in Canada's capital: A multi-methods exploration of the Medical Abortion Access Project.
    Contraception. 2022;109:37-42.
    PubMed     Abstract available

  228. BYRNE JJ, Smith EM, Saucedo AM, Doody KA, et al
    Accessibility to postpartum tubal ligation after a vaginal delivery: When the Medicaid policy is not a limiting factor.
    Contraception. 2022;109:52-56.
    PubMed     Abstract available

    April 2022
  229. MCCOOL-MYERS M, Kozlowski D, Jean V, Cordes S, et al
    The COVID-19 pandemic's impact on sexual and reproductive health in Georgia, USA: An exploration of behaviors, contraceptive care, and partner abuse.
    Contraception. 2022 Apr 27. pii: S0010-7824(22)00126.
    PubMed     Abstract available

  230. BURKE HM, Packer C, Fuchs R, Brache V, et al
    Acceptability of the contraceptive Sayana(R) Press when injected every four months: Results from a 12-month trial in Brazil, Chile and the Dominican Republic.
    Contraception. 2022 Apr 26. pii: S0010-7824(22)00124.
    PubMed     Abstract available

  231. STORCK KE, Gawron LM, Sanders JN, Wiaderny N, et al
    "I just had to pay the money and be supportive": A qualitative exploration of the male-partner role in contraceptive decision-making in Salt Lake City, Utah family planning clinics.
    Contraception. 2022 Apr 22. pii: S0010-7824(22)00109.
    PubMed     Abstract available

  232. MONIZ MH, Spector-Bagdady K, Perritt JB, Heisler M, et al
    Balancing Enhanced Contraceptive Access with Risk of Reproductive Injustice: A United States Comparative Case Study.
    Contraception. 2022 Apr 16. pii: S0010-7824(22)00105.
    PubMed     Abstract available

  233. MANZER JL, Berndt VK, Bell AV
    Comparing methods of long-acting reversible contraception: A qualitative study of Delaware women's perceptions of intrauterine devices and the implant.
    Contraception. 2022 Apr 10. pii: S0010-7824(22)00104.
    PubMed     Abstract available

  234. HARGRAVE AS, Ong A, Raza Z, Franco C, et al
    Opportunities for improving provision of emergency contraception in California.
    Contraception. 2022 Apr 2. pii: S0010-7824(22)00102.
    PubMed     Abstract available

  235. LEROY L, West AM, Hall C, Thomas D, et al
    A Real-World Comparison of In-Person vs. Virtual Contraceptive Care Trainings for Clinicians and Support Staff.
    Contraception. 2022 Apr 1. pii: S0010-7824(22)00082.
    PubMed     Abstract available

  236. RODRIGUEZ MI, Skye M, Samandari G, Darney BG, et al
    Timing of postpartum long acting, reversible contraception was not associated with 12-month removal rates in a large Medicaid sample.
    Contraception. 2022 Apr 1. pii: S0010-7824(22)00080.
    PubMed     Abstract available

  237. GILBERT AL, Amico JR
    Dilation and evacuation with an abdominal cerclage at 21 weeks gestation: A case report.
    Contraception. 2022;108:78-79.
    PubMed     Abstract available

  238. DRAGOMAN M, Fofie C, Bergen S, Chavkin W, et al
    Integrating self-managed medication abortion with medical care.
    Contraception. 2022;108:1-3.
    PubMed     Abstract available

    March 2022
  239. WU JP, Johnson E, Taichman LS
    Contraceptive decisions among individuals with medical conditions in Michigan, USA: A qualitative explanatory model informed by the Health Belief Model and the principle of respect for patient autonomy.
    Contraception. 2022 Mar 26. pii: S0010-7824(22)00084.
    PubMed     Abstract available

  240. MELBOSTAD HS, Wachtel DS, Lipke KA, Badger GJ, et al
    Preliminary Side Effect Profile, Safety, and Tolerability of Hormonal Contraception Among Women Receiving Opioid-Agonist Therapy.
    Contraception. 2022 Mar 10. pii: S0010-7824(22)00061.
    PubMed     Abstract available

  241. HURTADO ACM, Crowley SM, Landry KM, Landry MS, et al
    Telehealth Contraceptive Care in 2018: A Quality Improvement Study of Barriers to Access and Patient Satisfaction.
    Contraception. 2022 Mar 6. pii: S0010-7824(22)00059.
    PubMed     Abstract available

  242. ELIASON EL, Spishak-Thomas A, Steenland MW
    Title: Association of the Affordable Care Act Medicaid Expansions with Postpartum Contraceptive Use and Early Postpartum Pregnancy.
    Contraception. 2022 Mar 5. pii: S0010-7824(22)00060.
    PubMed     Abstract available

    Healthcare Access and Contraceptive Use among Adult Women in the United States in 2017.
    Contraception. 2022 Mar 3. pii: S0010-7824(22)00056.
    PubMed     Abstract available

  244. SHIN RJ, Yao M, Akesson C, Blazel M, et al
    An exploratory study comparing the quality of contraceptive counseling provided via telemedicine versus in-person visits.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00053.
    PubMed     Abstract available

  245. DOAN YP, Lehman EB, Chuang CH
    Effect of Neighborhood-Level Income on Access to Emergency Contraception.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00054.
    PubMed     Abstract available

  246. WIMSETT DJ, Sadler DL, Tutty DS, Tutty DE, et al
    Pregnancy planning and barriers to accessing postnatal contraception in New Zealand.
    Contraception. 2022 Mar 2. pii: S0010-7824(22)00055.
    PubMed     Abstract available

  247. UHM S, Mastey N, Baker CC, Chen MJ, et al
    Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study.
    Contraception. 2022;107:23-28.
    PubMed     Abstract available

  248. GROSSMAN D, Raifman S, Morris N, Arena A, et al
    Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment.
    Contraception. 2022;107:36-41.
    PubMed     Abstract available

  249. SHAY RL, Benson LS, Lokken EM, Micks EA, et al
    Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study.
    Contraception. 2022;107:29-35.
    PubMed     Abstract available

    February 2022
  250. DEHINGIA N, Barker KM, Raj A
    Relationship between adolescent friendship networks and contraceptive use and unintended pregnancies in early adulthood in the United States.
    Contraception. 2022 Feb 21. pii: S0010-7824(22)00032.
    PubMed     Abstract available

    The FDA ought to change Plan B's label.
    Contraception. 2022;106:6-9.
    PubMed     Abstract available

  252. CREININ M, Kohn JE, Tang JH, Serna TB, et al
    Society of Family Planning Committee statement on IUD nomenclature.
    Contraception. 2022;106:1-2.

    January 2022
  253. KUMNICK A, Hanfling SN, Dowlut-McElroy T, Maher JY, et al
    An Intersectional Analysis of Contraceptive Types Chosen Among Sexual Minority Women: A Nationally Representative Study.
    Contraception. 2022 Jan 24. pii: S0010-7824(22)00009.
    PubMed     Abstract available

  254. KAKAR V, Kulkarni A, Holschuh C, Smirnova A, et al
    Contraception Information on the Websites of Student Health Centers in the United States.
    Contraception. 2022 Jan 24. pii: S0010-7824(22)00011.
    PubMed     Abstract available

  255. LERMA K, McBrayer A, Nathan S, Dehlendorf C, et al
    Use of a contraceptive decision support tool in the abortion care setting.
    Contraception. 2022 Jan 23. pii: S0010-7824(22)00010.
    PubMed     Abstract available

  256. ENDLER M, Li R, Gemzell-Danielsson K
    Effect of levonorgestrel emergency contraception on implantation and fertility: a review.
    Contraception. 2022 Jan 23. pii: S0010-7824(22)00006.
    PubMed     Abstract available

  257. THORMAN A, Engle A, Brintz B, Simmons RG, et al
    Quantitative and qualitative impact of One Key Question(R) on primary care providers' contraceptive counseling at routine preventive health visits.
    Contraception. 2022 Jan 14. pii: S0010-7824(22)00003.
    PubMed     Abstract available

  258. KAMUYANGO A, Yu T, Ao CK, Hu SC, et al
    The public-sector family planning program impact scores in association with long acting reversible contraceptive use among young women in 22 Sub-Saharan African countries; A pooled multi-level analysis.
    Contraception. 2022 Jan 11. pii: S0010-7824(21)00497.
    PubMed     Abstract available

  259. WALLACE R, Shih G
    Complex family planning - Demarginalizing abortion care requires uplifting primary care and non-CFP providers.
    Contraception. 2022;105:86.

  260. SINKEY RG, Blanchard CT, Maier J, Novara A, et al
    The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease.
    Contraception. 2022;105:55-60.
    PubMed     Abstract available

  261. GLASIER A, Sober S, Gasloli R, Goyal A, et al
    A review of the effectiveness of a progestogen-only pill containing norgestrel 75 microg/day.
    Contraception. 2022;105:1-6.
    PubMed     Abstract available

    December 2021
  262. LAZORWITZ A, Sheeder J, Teal S
    Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Contraception. 2021 Dec 29. pii: S0010-7824(21)00463.
    PubMed     Abstract available

  263. RODRIGUEZ MI, Skye M, Ramanadhan S, Schrote K, et al
    Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00475.
    PubMed     Abstract available

  264. THOMPSON RL, Hu J, Custodio P, Dart C, et al
    The use of serum segesterone acetate levels to assess adherence of trial participants with a contraceptive vaginal ring.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00477.
    PubMed     Abstract available

  265. MANN ES, Chen AM, Johnson CL
    Doctor Knows Best? Provider Bias in the Context of Contraceptive Counseling in the United States.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00472.
    PubMed     Abstract available

  266. CHRISTINE BE, Rose M, Victoria Z, P H, et al
    Comparing perceptions of long-acting reversible contraception among women during periods of incarceration and women attending a local clinic; an exploratory study.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00480.
    PubMed     Abstract available

  267. KAWATU J, Clark M, Saul K, Quimby KD, et al
    Increasing access to single-visit contraception in urban health care settings: Findings from a multi-site learning collaborative.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00465.
    PubMed     Abstract available

  268. ROLAND N, Drouin J, Desplas D, Duranteau L, et al
    Impact of Coronavirus Disease 2019 (COVID-19) On Contraception Use in 2020 and up until the end of April 2021 in France.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00464.
    PubMed     Abstract available

  269. CHALMIERS MA, Karaki F, Muriki M, Mody S, et al
    Refugee women's experiences with contraceptive care after resettlement in high-income countries: A Critical Interpretive Synthesis.
    Contraception. 2021 Dec 28. pii: S0010-7824(21)00466.
    PubMed     Abstract available

  270. FOSTER DG, Gould H, Biggs MA
    Timing of pregnancy discovery among women seeking abortion().
    Contraception. 2021;104:642-647.
    PubMed     Abstract available

  271. ANGER HA, Raymond EG, Grant M, Haskell S, et al
    Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.
    Contraception. 2021;104:659-665.
    PubMed     Abstract available

  272. SHERPA LY, Tinkari BS, Gentle P, Sah RK, et al
    A prospective cohort study to assess the acceptability of Sayana Press among 18-49-year-old women in Nepal.
    Contraception. 2021;104:623-627.
    PubMed     Abstract available

    November 2021
  273. BEESHAM I, Bosman S, Beksinska M, Scoville CW, et al
    Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
    Contraception. 2021 Nov 27. pii: S0010-7824(21)00447.
    PubMed     Abstract available

  274. BERGLIN M, Stram D, Stenquist A, Dessi S, et al
    Contraception. 2021 Nov 27. pii: S0010-7824(21)00448.
    PubMed     Abstract available

  275. ANASTASIOU E, McCarthy KJ, Gollub EL, Ralph L, et al
    The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: a systematic review.
    Contraception. 2021 Nov 6. pii: S0010-7824(21)00445.
    PubMed     Abstract available

  276. WONG ZJ, Thompson L, Boulware A, Chen J, et al
    What You Don't Know Can Hurt You: Patient and Provider Perspectives on Postpartum Contraceptive Care in Illinois Catholic Hospitals.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00437.
    PubMed     Abstract available

  277. LI R, Ellington SR, Galang RR, Grosse SD, et al
    Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016-17 Zika virus outbreak.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00440.
    PubMed     Abstract available

  278. LUNDBERG BR, Tabuyo-Martin A, Ponzini MD, Wilson MD, et al
    Contraceptive plans before pre-operative assessment and at procedure in surgical abortion patients.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00444.
    PubMed     Abstract available

  279. JARUAMORNJIT Y, Kaewrudee S, Sothornwit J
    Differences in postpartum contraceptive choices and patterns following low- and high-risk pregnancy.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00442.
    PubMed     Abstract available

  280. HOPKINS K, Remington C, Eilers MA, Rivas SD, et al
    Obtaining buy-in for immediate postpartum long-acting reversible contraception programs in Texas hospitals: A qualitative study.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00434.
    PubMed     Abstract available

  281. SALEEM HT, Rosen JG, Quinn C, Duggaraju A, et al
    Contraception values and preferences of people living with HIV: a systematic review.
    Contraception. 2021 Nov 5. pii: S0010-7824(21)00433.
    PubMed     Abstract available

  282. DAM A, Yeh PT, Burke AE, Kennedy CE, et al
    Contraceptive values and preferences of pregnant women, postpartum women, women seeking emergency contraceptives, and women seeking abortion services: a systematic review.
    Contraception. 2021 Nov 3. pii: S0010-7824(21)00439.
    PubMed     Abstract available

  283. NIU F, Cornelius J, Aboubechara N, Saraj A, et al
    Real world outcomes related to providing an annual supply of short-acting hormonal contraceptives.
    Contraception. 2021 Nov 3. pii: S0010-7824(21)00435.
    PubMed     Abstract available

  284. EL-HADAD S, Villars P, Kahr MK, Leeners B, et al
    Removal of nonpalpable etonogestrel implants after fixation with a curved needle-A case series().
    Contraception. 2021;104:577-580.
    PubMed     Abstract available

  285. WHITE AL, Mann ES, Billings DL, Shah P, et al
    A qualitative exploration of men's perceptions of the terms "male sterilization" versus "vasectomy" in the southern United States.
    Contraception. 2021;104:524-530.
    PubMed     Abstract available

  286. GLASER K, Fix M, Karlin J, Schwarz EB, et al
    Awareness of the option of IUC self-removal among US adolescents.
    Contraception. 2021;104:567-570.
    PubMed     Abstract available

  287. HORGAN P, Thompson M, Harte K, Gee R, et al
    Termination of pregnancy services in Irish general practice from January 2019 to June 2019.
    Contraception. 2021;104:502-505.
    PubMed     Abstract available

    October 2021
  288. KWAL J, Maguire K, Carugno J
    Localization and Management of Nonpalpable Radiopaque Contraceptive Implant.
    Contraception. 2021 Oct 11. pii: S0010-7824(21)00412.

  289. JIAQI X, Shuxian W, Linlin Y, Li L, et al
    Does China's universal two-child policy affect contraceptive use among internal migrant women in China? Evidence based on panel data.
    Contraception. 2021 Oct 6. pii: S0010-7824(21)00404.
    PubMed     Abstract available

  290. DIMENSTEIN NB, Lindberg LD, Arrington-Sanders R, Jennings JM, et al
    Exploring experience of and engagement in coercive pregnancy behaviors among sexually active young men from five clinics in Baltimore, MD.
    Contraception. 2021;104:367-371.
    PubMed     Abstract available

  291. CHATROUX L, Darney BG, Skye M, Caughey AB, et al
    Examining the effect of unintended pregnancy on health utility using four measures.
    Contraception. 2021;104:344-349.
    PubMed     Abstract available

  292. ROE AH, McAllister A, Flynn AN, Martin B, et al
    The effect of mifepristone pretreatment on bleeding and pain during medical management of early pregnancy loss.
    Contraception. 2021;104:432-436.
    PubMed     Abstract available

  293. KLANGSIN S, Suwanrath C, Wattanakumtornkul S
    A case report of eosinophilia associated with an etonogestrel implant.
    Contraception. 2021;104:442-443.
    PubMed     Abstract available

    September 2021
  294. KAPLAN S, Bertoia ML, Wang FT, Zhou L, et al
    Long-term safety of extended levonorgestrel-containing oral contraceptives in the United States.
    Contraception. 2021 Sep 29. pii: S0010-7824(21)00406.
    PubMed     Abstract available

  295. RAINE-BENNETT T, Fassett MJ, Chandra M, Armstrong MA, et al
    Ectopic Pregnancy Prevention: Further Evidence of Benefits of Prescription Contraceptives.
    Contraception. 2021 Sep 18. pii: S0010-7824(21)00383.
    PubMed     Abstract available

  296. TEBB KP, Dehlendorf C, Rodriguez F, Fix M, et al
    Promoting Teen-to-Teen Contraceptive Communication with the SpeakOut Intervention, a Cluster Randomized Trial.
    Contraception. 2021 Sep 11. pii: S0010-7824(21)00377.
    PubMed     Abstract available

  297. BRINGLEY J, Zu V, Javlekar A, Daoud-Yilmaz F, et al
    Effects of Rotating at a Catholic Hospital on Medical Student Contraceptive Objective Structured Clinical Exam Scores.
    Contraception. 2021 Sep 7. pii: S0010-7824(21)00378.
    PubMed     Abstract available

  298. FURLAN RM, Garcia E, Castro S, Machado HC, et al
    Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception.
    Contraception. 2021 Sep 5. pii: S0010-7824(21)00374.
    PubMed     Abstract available

  299. SILVERSTEIN RG, Fitz V, Thornton M, Carter A, et al
    Contraceptive use and counseling in patients with systemic lupus erythematosus.
    Contraception. 2021 Sep 4. pii: S0010-7824(21)00376.
    PubMed     Abstract available

  300. SHELEF DQ, Raine-Bennett T, Chandra M, Adler N, et al
    The association between depression and contraceptive behaviors in a diverse sample of new prescription contraception users.
    Contraception. 2021 Sep 2. pii: S0010-7824(21)00373.
    PubMed     Abstract available

  301. FOK WK, Lerma K, Shaw KA, Blumenthal PD, et al
    Comparison of two home pregnancy tests for self-confirmation of medication abortion status: A randomized trial.
    Contraception. 2021;104:296-300.
    PubMed     Abstract available

    August 2021
  302. DIAMOND-SMITH N, Logan R, Marshall C, Corbetta-Rastelli C, et al
    COVID-19's impact on contraception experiences: exacerbation of structural inequities in women's health.
    Contraception. 2021 Aug 27. pii: S0010-7824(21)00369.
    PubMed     Abstract available

  303. ROE AH, Lang B, McAllister A, Gaitors MC, et al
    Contraceptive use and preferences among females with sickle cell disease.
    Contraception. 2021 Aug 18. pii: S0010-7824(21)00353.
    PubMed     Abstract available

  304. KREITCHMANN R, Stek A, Best BM, Capparelli E, et al
    Interactions Between Etonogestrel-Releasing Contraceptive Implant and Three Antiretroviral Regimens.
    Contraception. 2021 Aug 15. pii: S0010-7824(21)00350.
    PubMed     Abstract available

  305. STEENLAND MW, Geiger CK, Chen L, Rokicki S, et al
    Declines in Contraceptive Visits in the United States during the COVID-19 Pandemic.
    Contraception. 2021 Aug 14. pii: S0010-7824(21)00347.
    PubMed     Abstract available

  306. THOMPSON K, Kirschner JH, Irwin S, Lee A, et al
    Perceptions of Long-acting Reversible Contraception among Women in an Urban U.S. Jail.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00345.
    PubMed     Abstract available

  307. PAN YL, Beal L, Espino K, Sufrin CB, et al
    Female Permanent Contraception Policies and Occurrence at a Sample of U.S. Prisons and Jails.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00349.
    PubMed     Abstract available

  308. BROUSSARD K, Becker A
    Self-removal of long-acting reversible contraception: A content analysis of YouTube videos.
    Contraception. 2021 Aug 13. pii: S0010-7824(21)00346.
    PubMed     Abstract available

    Ethinyl estradiol and levonorgestrel patch phase 3 data clarification.
    Contraception. 2021;104:216.

  310. NELSON AL
    Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification.
    Contraception. 2021;104:217.

  311. LATACK KR, Patel J, Moog D, Spencer D, et al
    Withdrawal method inquiries and user experiences: An analysis of content posted on 4 gendered forums on Reddit.
    Contraception. 2021;104:170-175.
    PubMed     Abstract available

    July 2021
  312. AHRENS K, Skjeldestad FE
    Trends in initiation of hormonal contraceptive methods among teenagers born between 1989 and 1997 in Norway and the United States.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00339.
    PubMed     Abstract available

  313. WILKINSON TA, Edmonds BT, Cheng ER
    Outcomes of a Two-Visit Protocol for Long Acting Reversible Contraception for Adolescents and Young Adults.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00341.
    PubMed     Abstract available

  314. BROWN HK, Aker A, Wanigaratne S
    Multimorbidity and use of reversible contraception: Results from a Canadian cross-sectional survey.
    Contraception. 2021 Jul 27. pii: S0010-7824(21)00343.
    PubMed     Abstract available

  315. HARRISON MS, Jimenez-Zambrano A, Rivera C, Bunge-Montes S, et al
    Delivery of home-based postpartum contraception in Southwest Trifinio, Guatemala: reach, adoption, and implementation in a cluster-randomized trial.
    Contraception. 2021 Jul 13. pii: S0010-7824(21)00223.
    PubMed     Abstract available

  316. BARBOSA RM, Kalckmann S, Arilha M, Giacomodo Lago TD, et al
    The emergency contraceptive pill in Brazil: high usage rates but schooling differences persist.
    Contraception. 2021 Jul 2. pii: S0010-7824(21)00219.
    PubMed     Abstract available

  317. RODRIGUEZ MI, Meath T, Huang J, Darney BG, et al
    Association of rural location and long acting reversible contraceptive use among Oregon Medicaid recipients.
    Contraception. 2021 Jul 2. pii: S0010-7824(21)00218.
    PubMed     Abstract available

  318. DOHM J, Ji M
    An introduction to risk evaluation and mitigation strategies.
    Contraception. 2021;104:4-7.

  319. MARK A, Foster AM, Perritt J
    The future of abortion is now: Mifepristone by mail and in-clinic abortion access in the United States.
    Contraception. 2021;104:38-42.
    PubMed     Abstract available

    Abortion exceptionalism and the mifepristone REMS.
    Contraception. 2021;104:8-11.
    PubMed     Abstract available

  321. KERESTES C, Murayama S, Tyson J, Natavio M, et al
    Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Contraception. 2021;104:49-53.
    PubMed     Abstract available

  322. CHONG E, Shochet T, Raymond E, Platais I, et al
    Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic.
    Contraception. 2021;104:43-48.
    PubMed     Abstract available

  323. CLELAND K, Foster AM, Gomez AM, Raymond EG, et al
    Contraception Special Issue on the mifepristone Risk Evaluation and Mitigation Strategy (REMS).
    Contraception. 2021;104:1-3.

  324. THOMPSON A, Singh D, Ghorashi AR, Donovan MK, et al
    The disproportionate burdens of the mifepristone REMS.
    Contraception. 2021;104:16-19.

  325. MEURICE ME, Whitehouse KC, Blaylock R, Chang JJ, et al
    Client satisfaction and experience of telemedicine and home use of mifepristone and misoprostol for abortion up to 10 weeks' gestation at British Pregnancy Advisory Service: A cross-sectional evaluation.
    Contraception. 2021;104:61-66.
    PubMed     Abstract available

  326. STONE RH, Rafie S
    Medication abortion: Advocating for mifepristone dispensing by pharmacists.
    Contraception. 2021;104:31-32.

  327. KAYE J, Reeves R, Chaiten L
    The mifepristone REMS: A needless and unlawful barrier to care.
    Contraception. 2021;104:12-15.
    PubMed     Abstract available

  328. SRINIVASULU S, Yavari R, Brubaker L, Riker L, et al
    US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Contraception. 2021;104:92-97.
    PubMed     Abstract available

  329. CALLOWAY D, Stulberg DB, Janiak E
    Mifepristone restrictions and primary care: Breaking the cycle of stigma through a learning collaborative model in the United States.
    Contraception. 2021;104:24-28.
    PubMed     Abstract available

  330. RAIDOO S, Kaneshiro B, Stowers P
    Guam: The US territory where America's day begins but abortion access is still in the dark.
    Contraception. 2021;104:33-35.
    PubMed     Abstract available

  331. GLASER K, Whitehair J
    Missing mifepristone at tribal health facilities serving native Americans.
    Contraception. 2021;104:36-37.
    PubMed     Abstract available

  332. DANIEL S, Schulkin J, Grossman D
    Obstetrician-gynecologist willingness to provide medication abortion with removal of the in-person dispensing requirement for mifepristone.
    Contraception. 2021;104:73-76.
    PubMed     Abstract available

  333. RASMUSSEN KN, Janiak E, Cottrill AA, Stulberg DB, et al
    Expanding access to medication abortion through pharmacy dispensing of mifepristone: Primary care perspectives from Illinois.
    Contraception. 2021;104:98-103.
    PubMed     Abstract available

    June 2021
  334. FAY KE, Clement AC, Gero A, Kaiser JE, et al
    Rates of pregnancy among levonorgestrel and copper intrauterine emergency contraception initiators: implications for backup contraception recommendations.
    Contraception. 2021 Jun 21. pii: S0010-7824(21)00210.
    PubMed     Abstract available

  335. BRACHE V, Vieira CS, Plagianos M, Lansiaux M, et al
    Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: a randomized proof-of-concept study.
    Contraception. 2021 Jun 19. pii: S0010-7824(21)00193.
    PubMed     Abstract available

  336. NGUYEN BT, Yuen F, Farrant M, Thirumalai A, et al
    Acceptability of the oral hormonal male contraceptive prototype, 11beta-Methyl-19-nortestosterone dodecylcarbonate (11beta-MNTDC), in a 28-day placebo-controlled trial.
    Contraception. 2021 Jun 18. pii: S0010-7824(21)00192.
    PubMed     Abstract available

  337. LAVELANET AF, Ralph JA, Ti A, Duggaraju A, et al
    A systematic review exploring the contraception values and preferences of sex workers, transmasculine individuals, people who inject drugs, and those living in humanitarian contexts.
    Contraception. 2021 Jun 18. pii: S0010-7824(21)00191.
    PubMed     Abstract available

  338. LEW J, Sheeder J, Lazorwitz A
    Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients.
    Contraception. 2021 Jun 17. pii: S0010-7824(21)00190.
    PubMed     Abstract available

  339. ZEAL C, Paul R, Dorsey M, Politi MC, et al
    Young women's preferences for contraceptive education: the importance of the clinician.
    Contraception. 2021 Jun 14. pii: S0010-7824(21)00188.
    PubMed     Abstract available

  340. NGUYEN BT, Brown AL, Jones F, Jones L, et al
    "I'm not going to be a guinea pig:" medical mistrust as a barrier to male contraception for Black American men in Los Angeles, CA.
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00184.
    PubMed     Abstract available

  341. GYLLENBERG F, Tekay A, Saloranta T, Korjamo R, et al
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00186.
    PubMed     Abstract available

  342. SOBEL L, Lee YW, White KO, Woodhams E, et al
    Contraceptive decision making among pregnancy-capable individuals with opioid use disorder at a tertiary care center in Massachusetts.
    Contraception. 2021 Jun 9. pii: S0010-7824(21)00185.
    PubMed     Abstract available

  343. RODRIGUEZ MI, Kaufman M, Manibusan B, Anderson L, et al
    Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist.
    Contraception. 2021 Jun 8. pii: S0010-7824(21)00187.
    PubMed     Abstract available

  344. LIN TK, Law R, Beaman J, Foster DG, et al
    The impact of the COVID-19 pandemic on economic security and pregnancy intentions among people at risk of pregnancy.
    Contraception. 2021;103:380-385.
    PubMed     Abstract available

  345. GILLIAM ML, Jensen JT, Eisenberg DL, Thomas MA, et al
    Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years.
    Contraception. 2021;103:444-449.
    PubMed     Abstract available

  346. RAYMOND EG, Anger HA, Chong E, Haskell S, et al
    "False positive" urine pregnancy test results after successful medication abortion.
    Contraception. 2021;103:400-403.
    PubMed     Abstract available

  347. FLYNN AN, Roe AH, Koelper N, McAllister A, et al
    Timing and efficacy of mifepristone pretreatment for medical management of early pregnancy loss.
    Contraception. 2021;103:404-407.
    PubMed     Abstract available

    May 2021
  348. RIVAS K, Schmuhl NB, Taboada M, Godecker A, et al
    Are Wisconsin resident physicians trained in immediate postpartum long acting reversible contraception?
    Contraception. 2021 May 31. pii: S0010-7824(21)00176.
    PubMed     Abstract available

  349. GOYAL V, Madison AM, Powers DA, Potter JE, et al
    Impact of Contraceptive Counseling on Texans Who Can and Cannot Receive No-Cost Post-Abortion Contraception.
    Contraception. 2021 May 30. pii: S0010-7824(21)00178.
    PubMed     Abstract available

  350. TI A, Soin K, Rahman T, Dam A, et al
    Contraceptive values and preferences of adolescents and young adults: a systematic review.
    Contraception. 2021 May 30. pii: S0010-7824(21)00179.
    PubMed     Abstract available

  351. KRAMER RD, Higgins JA, Burns ME, Stulberg DB, et al
    Expectations about Availability of Contraception and Abortion at a Hypothetical Catholic Hospital: Rural-Urban Disparities among Wisconsin Women.
    Contraception. 2021 May 28. pii: S0010-7824(21)00175.
    PubMed     Abstract available

  352. LASSAR M, Tao K, Bond T, Qadir S, et al
    Closing the contraceptive coverage gap: a multi-pronged approach to advancing reproductive equity in Illinois.
    Contraception. 2021 May 27. pii: S0010-7824(21)00157.
    PubMed     Abstract available

  353. KHIN YP, Nawa N, Fujiwara T, Surkan PJ, et al
    Access to contraceptive services among Myanmar women living in Japan: A qualitative study.
    Contraception. 2021 May 26. pii: S0010-7824(21)00155.
    PubMed     Abstract available

  354. SONG B, White VanGompel E, Wang C, Guzman S, et al
    Corrigendum to "Effects of Clinic-level Implementation of One Key Question(R) on Reproductive Health Counseling and Patient Satisfaction" [Contraception 103 (2021): 6-12].
    Contraception. 2021 May 25. pii: S0010-7824(21)00113.

  355. VEGA A, Choi YJ, Tschann M, Salcedo J, et al
    Over-the-Counter Access to Levonorgestrel Emergency Contraception in South Texas: Does Over-the-Counter Mean Ready to Buy?
    Contraception. 2021 May 21. pii: S0010-7824(21)00152.
    PubMed     Abstract available

  356. GIFFORD K, McDuffie MJ, Rashid H, Knight EK, et al
    Postpartum contraception method type and risk of a short inter-pregnancy interval in a state Medicaid population.
    Contraception. 2021 May 20. pii: S0010-7824(21)00153.
    PubMed     Abstract available

  357. CREININ MD, Westhoff CL, Bouchard C, Chen MJ, et al
    Estetrol-Drospirenone Combination Oral Contraceptive: North American Phase 3 Efficacy and Safety Results.
    Contraception. 2021 May 14. pii: S0010-7824(21)00149.
    PubMed     Abstract available

  358. KEOGH SC, Otupiri E, Castillo PW, Chiu DW, et al
    Hormonal contraceptive use in Ghana: the role of method attributes and side effects in method choice and continuation.
    Contraception. 2021 May 13. pii: S0010-7824(21)00151.
    PubMed     Abstract available

    April 2021
  359. COMFORT AB, Harper CC, Tsai AC, Moody J, et al
    Social and provider networks and women's contraceptive use: Evidence from Madagascar.
    Contraception. 2021 Apr 23. pii: S0010-7824(21)00129.
    PubMed     Abstract available

  360. ARIYO O, Khoury AJ, Smith MG, Leinaar E, et al
    From Training to Implementation: Improving Contraceptive Practices in South Carolina.
    Contraception. 2021 Apr 21. pii: S0010-7824(21)00132.
    PubMed     Abstract available

  361. DEV R, Kohler P, Begnel E, Achwoka D, et al
    Contraceptive counseling experiences among women attending HIV Care and Treatment Centers: a national survey in Kenya.
    Contraception. 2021 Apr 21. pii: S0010-7824(21)00127.
    PubMed     Abstract available

  362. STIFANI BM, Smith A, Avila K, Boos EW, et al
    Telemedicine for contraceptive counseling: patient experiences during the early phase of the Covid-19 pandemic in New York City.
    Contraception. 2021 Apr 13. pii: S0010-7824(21)00111.
    PubMed     Abstract available

  363. HUBER-KRUM S, Bornstein M, Garver S, Gipson J, et al
    Are rural Malawian women using their preferred contraceptive method and that of their male partners?
    Contraception. 2021 Apr 3. pii: S0010-7824(21)00100.
    PubMed     Abstract available

  364. BOUMA-JOHNSTON H, Ponsaran R, Arora KS
    Variation by state in Medicaid sterilization policies for physician reimbursement.
    Contraception. 2021;103:255-260.
    PubMed     Abstract available

    March 2021
  365. LIU JH, Plagianos M, Archer DF, Simon JA, et al
    Segesterone Acetate Serum Levels with a Regression Model of Continuous Use of the Segesterone Acetate/Ethinyl Estradiol Contraceptive Vaginal System.
    Contraception. 2021 Mar 27. pii: S0010-7824(21)00096.
    PubMed     Abstract available

  366. HADDAD LB, RamaRao S, Hazra A, Birungi H, et al
    Addressing contraceptive needs exacerbated by COVID-19: A call for increasing choice and access to self-managed methods.
    Contraception. 2021 Mar 26. pii: S0010-7824(21)00095.
    PubMed     Abstract available

  367. BONIFACE ER, Rodriguez MI, Heintzman J, Knipper S, et al
    Contraceptive provision in Oregon School-Based Health Centers: Method type trends and the role of Title X.
    Contraception. 2021 Mar 26. pii: S0010-7824(21)00092.
    PubMed     Abstract available

  368. BREWER M, Stevens L
    Use of Fertility Awareness-Based Methods of Contraception: Evidence from the National Survey of Family Growth, 2013-17.
    Contraception. 2021 Mar 21. pii: S0010-7824(21)00086.
    PubMed     Abstract available

  369. SKRACIC I, Lewin AB, Roy KM
    Evaluation of the Delaware Contraceptive Access Now (DelCAN) initiative: A qualitative analysis of site leaders' implementation recommendations.
    Contraception. 2021 Mar 21. pii: S0010-7824(21)00087.
    PubMed     Abstract available

  370. TEBB KP, Rodriguez F, Pollack LM, Adams S, et al
    Improving Contraceptive Use Among Latina Adolescents: A Cluster-Randomized Controlled Trial Evaluating an mHealth Application, Health-E You/Salud iTu.
    Contraception. 2021 Mar 17. pii: S0010-7824(21)00059.
    PubMed     Abstract available

  371. DUIJKERS I, Klipping C, Kinet V, Jost M, et al
    Effects of an oral contraceptive containing estetrol and drospirenone on ovarian function.
    Contraception. 2021 Mar 6. pii: S0010-7824(21)00058.
    PubMed     Abstract available

  372. GAFFIELD ME, Kiarie J
    Setting global standards: The paramount importance of considering contraceptive values and preferences of clients and providers.
    Contraception. 2021 Mar 5. pii: S0010-7824(18)30399.

    Contraceptive counseling following in-clinic pregnancy test among women not expecting pregnancy in the next two years: Disparities by service delivery setting and sociodemographic characteristics.
    Contraception. 2021 Mar 2. pii: S0010-7824(21)00055.
    PubMed     Abstract available

  374. DRAGOMAN MV, Grossman D, Nguyen MH, Habib N, et al
    Two prophylactic pain management regimens for medical abortion
    Contraception. 2021;103:163-170.
    PubMed     Abstract available

  375. NELSON AL, Kaunitz AM, Kroll R, Simon JA, et al
    Efficacy, safety, and tolerability of a levonorgestrel/ethinyl estradiol transdermal delivery system: Phase 3 clinical trial results.
    Contraception. 2021;103:137-143.
    PubMed     Abstract available

    February 2021
  376. THORNTON O, Daggett E, Zia L, Quian A, et al
    Counseling, Contraception, and Conception Rates in Patients Undergoing Bariatric Surgery: A Retrospective Review.
    Contraception. 2021 Feb 28. pii: S0010-7824(21)00053.
    PubMed     Abstract available

  377. STEINBERG JR, Marthey D, Xie L, Boudreaux M, et al
    Contraceptive method type and satisfaction, confidence in use, and switching intentions.
    Contraception. 2021 Feb 20. pii: S0010-7824(21)00051.
    PubMed     Abstract available

  378. LATACK KR, Yuen F, Wang C, Nguyen BT, et al
    Online community queries on hormonal male contraception: an analysis of the Reddit "Ask Me Anything" experience.
    Contraception. 2021 Feb 19. pii: S0010-7824(21)00050.
    PubMed     Abstract available

  379. CHAKRABORTY P, Gallo MF, Nawaz S, Smith M, et al
    Use of non-preferred contraceptive methods among women in Ohio.
    Contraception. 2021 Feb 16. pii: S0010-7824(21)00035.
    PubMed     Abstract available

  380. BERNDT VK, Bell AV
    Contextualizing Barriers to Long-Acting Reversible Contraception.
    Contraception. 2021 Feb 16. pii: S0010-7824(21)00036.
    PubMed     Abstract available

  381. BELL SO, Gemmill A
    Perceived likelihood of becoming pregnant and contraceptive use: Findings from population-based surveys in Cote d'Ivoire, Nigeria, and Rajasthan, India.
    Contraception. 2021 Feb 12. pii: S0010-7824(21)00031.
    PubMed     Abstract available

  382. MASTEY N, Matulich MC, Uhm S, Baker CC, et al
    U.S. referral center experience removing nonpalpable and difficult contraceptive implants with in-office ultrasonography: a case series.
    Contraception. 2021 Feb 8. pii: S0010-7824(21)00028.
    PubMed     Abstract available

  383. GIPSON JD, Bornstein M, Berger A, Rocca CH, et al
    Desire to Avoid Pregnancy and Contraceptive Use among Female Methadone Patients in Los Angeles.
    Contraception. 2021 Feb 7:9564. doi: 10.1016/j.contraception.2021.
    PubMed     Abstract available

  384. KIM C, Nguyen AT, Berry-Bibee E, Ermias Y, et al
    Systemic hormonal contraception initiation after abortion: a systematic review and meta-analysis.
    Contraception. 2021 Feb 3. pii: S0010-7824(21)00027.
    PubMed     Abstract available

  385. CANNON R, White K, Seifert B, Woodhams E, et al
    Exploring The Physician's Role in Contraceptive Counseling at the Time of Abortion in the US.
    Contraception. 2021 Feb 2. pii: S0010-7824(21)00024.
    PubMed     Abstract available

  386. GOLDMAN AR, Gerber SR
    Levonorgestrel intrauterine system (IUS) in a patient with uterine didelphys: A case report.
    Contraception. 2021;103:134-135.
    PubMed     Abstract available

    January 2021
  387. DUTTON C, Kim R, Janiak E
    Prevalence of contraindications to progestin-only contraceptive pills in a multi-institution patient database.
    Contraception. 2021 Jan 30. pii: S0010-7824(21)00020.
    PubMed     Abstract available

  388. CLELAND K, Marcantonio TL, Hunt ME, Jozkowski KN, et al
    "It prevents a fertilized egg from attaching...and causes a miscarriage of the baby": A qualitative assessment of how people understand the mechanism of action of emergency contraceptive pills.
    Contraception. 2021 Jan 25. pii: S0010-7824(21)00019.
    PubMed     Abstract available

  389. DEHLENDORF C, Fox E, Silverstein IA, Hoffman A, et al
    Development of the Patient-Centered Contraceptive Counseling scale (PCCC), a short form of the Interpersonal Quality of Family Planning Care scale.
    Contraception. 2021 Jan 25. pii: S0010-7824(21)00018.
    PubMed     Abstract available

  390. KRASHIN JW, Zapata LB, Morgan IA, Tepper NK, et al
    Required examinations and tests before initiating contraception: provider practices from a national cross-sectional survey.
    Contraception. 2021 Jan 14. pii: S0010-7824(21)00006.
    PubMed     Abstract available

  391. WILLIAMS BN, Jauk VC, Szychowski JM, Arbuckle JL, et al
    Adolescent Emergency Contraception Usage, Knowledge and Perception.
    Contraception. 2021 Jan 13. pii: S0010-7824(21)00005.
    PubMed     Abstract available

  392. KLIPPING C, Duijkers I, Mawet M, Maillard C, et al
    Endocrine and metabolic effects of an oral contraceptive containing estetrol and drospirenone.
    Contraception. 2021 Jan 8. pii: S0010-7824(21)00002.
    PubMed     Abstract available

  393. HYLTON-KONG T, Steiner MJ, Bailey A, Palazzi M, et al
    Debunking myths about contraceptive safety among women in Kingston, Jamaica: Pilot randomized controlled trial.
    Contraception. 2021 Jan 8. pii: S0010-7824(21)00003.
    PubMed     Abstract available

  394. EVANS ML, Qasba N, Shah Arora K
    COVID-19 highlights the policy barriers and complexities of postpartum sterilization.
    Contraception. 2021;103:3-5.
    PubMed     Abstract available

  395. CARR BR, Thomas MA, Gangestad A, Eisenberg DL, et al
    Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta(R)) discontinuation.
    Contraception. 2021;103:26-31.
    PubMed     Abstract available

  396. SEIDMAN D, Cavrois M, Hilton JF, Roan NR, et al
    Reproductive tract immune cells from pregnant women or those using depot medroxyprogesterone acetate show no excess susceptibility to HIV-1: Results of an ex vivo fusion assay.
    Contraception. 2021;103:44-47.
    PubMed     Abstract available

    December 2020
  397. CHE Y, Li Y, Gu X, Jiang L, et al
    Contraception, unintended pregnancy, and induced abortion within 24 months of delivery in China: a retrospective cohort study.
    Contraception. 2020 Dec 27. pii: S0010-7824(20)30467.
    PubMed     Abstract available

  398. EGARDT A, Algovik M, Kallner HK
    Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortion.
    Contraception. 2020 Dec 26. pii: S0010-7824(20)30466.
    PubMed     Abstract available

  399. ELLISON J, Cole MB, Hanchate AD, Kazis L, et al
    Non-Indicated Pelvic Examinations During Contraceptive Encounters: Prevalence and Provider Variations.
    Contraception. 2020 Dec 26. pii: S0010-7824(20)30464.
    PubMed     Abstract available

  400. BESHAR I, So J, Chelvakumar M, Cahill EP, et al
    Socioeconomic Differences Persist in Use of Permanent versus Long-Acting Reversible Contraception: An Analysis of the National Survey for Family Growth, 2006-2010 versus 2015-2017.
    Contraception. 2020 Dec 23. pii: S0010-7824(20)30461.
    PubMed     Abstract available

  401. NAMKUNG EH, Valentine A, Warner L, Mitra M, et al
    Contraceptive Use at First Sexual Intercourse among Adolescent and Young Adult Women with Disabilities: The Role of Formal Sex Education.
    Contraception. 2020 Dec 23. pii: S0010-7824(20)30460.
    PubMed     Abstract available

  402. SUNAGA T, Cicali B, Schmidt S, Brown J, et al
    Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system.
    Contraception. 2020 Dec 17. pii: S0010-7824(20)30439.
    PubMed     Abstract available

  403. HARRIS S, Kaneshiro B, Ahn HJ, Saito-Tom L, et al
    Timing of Insertion Affects Expulsion in Patients using the Levonorgestrel 52 mg Intrauterine System for Non-Contraceptive Indications.
    Contraception. 2020 Dec 5. pii: S0010-7824(20)30435.
    PubMed     Abstract available

  404. Corrigendum to "Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate" [Contraception 102(3) (2020) 168-173].
    Contraception. 2020;102:433.

  405. KATZ M, Newmark RL, Aronstam A, O'Grady N, et al
    An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA).
    Contraception. 2020;102:392-395.
    PubMed     Abstract available

    November 2020
  406. KIM CS, Lunde B, MacIsaac L, Arden M, et al
    Provision of Contraceptive Implants in School-Based Health Centers: A Cost-Effectiveness Analysis.
    Contraception. 2020 Nov 19. pii: S0010-7824(20)30420.
    PubMed     Abstract available

  407. STIFANI BM, Avila K, Levi EE
    Telemedicine for contraceptive counseling: an exploratory survey of US family planning providers following rapid adoption of services during the COVID-19 pandemic.
    Contraception. 2020 Nov 16. pii: S0010-7824(20)30416.
    PubMed     Abstract available

  408. SUMARSONO A, Segar MW, PharmD LX, Atem F, et al
    Medicaid Expansion and Provision of Prescription Contraception to Medicaid Beneficiaries.
    Contraception. 2020 Nov 16. pii: S0010-7824(20)30415.
    PubMed     Abstract available

  409. SHETH AN, Angert CD, Haddad LB, Mehta CC, et al
    Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011.
    Contraception. 2020 Nov 12. pii: S0010-7824(20)30414.
    PubMed     Abstract available

  410. CHARLTON BM, Reynolds CA, Janiak E, DiVasta AD, et al
    Sexual orientation-related differences in contraceptive use: a brief report based on a cohort of adolescent and young women.
    Contraception. 2020 Nov 12. pii: S0010-7824(20)30412.
    PubMed     Abstract available

  411. STRANSKY OM, Wolgemuth T, Kazmerski T, Chodoff A, et al
    Contraception Decision-Making and Care Among Reproductive-Aged Women with Autoimmune Diseases.
    Contraception. 2020 Nov 9. pii: S0010-7824(20)30406.
    PubMed     Abstract available

  412. HUYSMAN BC, Paul R, Rivera AN, Tal E, et al
    Patient and counselor satisfaction with structured contraceptive counseling by health center staff in federally qualified health centers.
    Contraception. 2020 Nov 5. pii: S0010-7824(20)30405.
    PubMed     Abstract available

    October 2020
  413. ECKHAUS LM, Ti AJ, Curtis KM, Stewart-Lynch AL, et al
    Patient and pharmacist perspectives on pharmacist-prescribed contraception: a systematic review.
    Contraception. 2020 Oct 29. pii: S0010-7824(20)30382.
    PubMed     Abstract available

  414. BUASAWAT P, Manonai J, Ngamjanyaporn P
    Perception of Contraceptive Counseling and Contraceptive Use among Systemic Lupus Erythematosus Patients.
    Contraception. 2020 Oct 29. pii: S0010-7824(20)30387.
    PubMed     Abstract available

  415. UHM S, Chen MJ, Cutler ED, Creinin MD, et al
    Twelve-month prescribing of contraceptive pill, patch, and ring before and after a standardized electronic medical record order change.
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30381.
    PubMed     Abstract available

  416. HAVERINEN A, Kangasniemi M, Luiro K, Piltonen T, et al
    Ethinyl Estradiol vs Estradiol Valerate in Combined Oral Contraceptives - Effect on Glucose Tolerance: A Randomized, Controlled Clinical Trial.
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30384.
    PubMed     Abstract available

  417. CHIRUVELLA M, Schaffir J, Benedict JA, Tedesco C, et al
    Is provision of contraception at discharge following delivery associated with postpartum visit attendance?
    Contraception. 2020 Oct 21. pii: S0010-7824(20)30385.
    PubMed     Abstract available

  418. EHN B, Anderberg P, Sanmartin Berglund J, Lilje S, et al
    The process of opting for female permanent contraception: A qualitative study of women's experiences in Sweden.
    Contraception. 2020 Oct 14. pii: S0010-7824(20)30359.
    PubMed     Abstract available

  419. ARCARA J, Arteaga S, Burny I, Manchikanti Gomez A, et al
    Changes in Expectation of Relationship Permanence, Pregnancy Acceptability and Desire, and Contraceptive Use Over Time Among Young Latino/a Women and Men: An Exploratory Analysis.
    Contraception. 2020 Oct 7. pii: S0010-7824(20)30356.
    PubMed     Abstract available

    September 2020
  420. PETERSON SF, Blumenthal PD
    Intra-abdominal placement of postplacental levonorgestrel intrauterine system: A case report.
    Contraception. 2020;102:224.

  421. CARUGNO J
    Post-placental intra-abdominal placement of levonorgestrel 52mg intrauterine system: A case report.
    Contraception. 2020;102:222-223.

    April 2020
  422. RODEN RC, Noritz G, McKnight ER, Bonny AE, et al
    An exploratory study of depot-medroxyprogesterone acetate and bone mineral density in adolescent and young adult women with cerebral palsy.
    Contraception. 2020;101:273-275.
    PubMed     Abstract available

  423. STULBERG DB, Datta A, White VanGompel E, Schueler K, et al
    One Key Question(R) and the Desire to Avoid Pregnancy Scale: A comparison of two approaches to asking about pregnancy preferences.
    Contraception. 2020;101:231-236.
    PubMed     Abstract available

  424. LAROCHE KJ, Wynn LL, Foster AM
    "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    Contraception. 2020;101:256-260.
    PubMed     Abstract available

  425. DENNIS A, Manski R, O'Donnell J
    Assessing research impact: A framework and an evaluation of the Society of Family Planning Research Fund's grantmaking (2007-2017).
    Contraception. 2020;101:213-219.
    PubMed     Abstract available

    March 2020
  426. LAPORTE M, Marangoni M Jr, Surita F, Juliato CT, et al
    Postplacental placement of intrauterine devices: A randomized clinical trial.
    Contraception. 2020;101:153-158.
    PubMed     Abstract available

  427. SRINIVASULU S, Shah SD, Schechter CB, Prine L, et al
    Effectiveness of clinical decision support to enhance delivery of family planning services in primary care settings.
    Contraception. 2020;101:199-204.
    PubMed     Abstract available

    February 2020
  428. MANZE MG, Calixte C, Romero DR, Roberts L, et al
    Physician perspectives on routine pregnancy intention screening and counseling in primary care.
    Contraception. 2020;101:91-96.
    PubMed     Abstract available

  429. RICHTER WH, Koytchev R, Kirkov V, Merki G, et al
    Comparative pharmacokinetic estimates of drospirenone alone and in combination with ethinyl estradiol after single and repeated oral administration in healthy females.
    Contraception. 2020;101:137-143.
    PubMed     Abstract available

    January 2020
  430. KAPP N, Methazia J, Eckersberger E, Griffin R, et al
    Label comprehension of a combined mifepristone and misoprostol product for medical abortion: A pilot study in South Africa.
    Contraception. 2020;101:46-52.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Contraception and Contraceptive Drugs is free of charge.